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COMPENDIUM (Italian/English) 
 
(Italian) 
 
Le diete chetogeniche sono diete in cui l’introito netto di carboidrati, calcolato sottraendo la quantità di fibre dai 
carboidrati totali, è tra 20 e 50 g/gg (<10% dell’apporto energetico totale) con una proporzione variabile di 
proteine e grassi (Noakes, Windt 2017). In queste condizioni le riserve di glicogeno sono esaurite (Paoli, Canato 
et al. 2011), il livello di insulina è basso e il metabolismo energetico dipende prevalentemente dall’ossidazione 
dei grassi. Le diete chetogeniche portano un aumento significativo dei livelli circolanti dei corpi chetonici β-
idrossibutirrato, acetoacetato e acetone (Veldhorst, Westerterp et al. 2010). Mentre sia l’acetoacetato che il β-
idrossibutirrato vengono utilizzati come energia, l’acetone è volatile ed è eliminato attraverso l’espirazione, 
dando all’alito quella nota “fruttata” tipica della chetosi, oppure attraverso i reni (Paoli, Canato et al. 2011). La 
concentrazione ematica dei corpi chetonici in individui sani che seguono una dieta costituita prevalentemente da 
carboidrati è 0,1 mmol/L e può salire fino a 0,3 mmol/L dopo il digiuno notturno, ma dopo venti giorni di 
digiuno il livello di corpi chetonici può salire oltre 10 mmol/L. Una dieta è considerata “chetogenica” quando 
produce un aumento del livello di β-idrossibutirrato superiore a 0,6 mmol/L (Wiggam, O'Kane et al. 1997) 
oppure se il rapporto molare tra il glucosio e il β-idrossibutirrato ematici è uguale o minore di 1 (Meidenbauer, 
Mukherjee et al. 2015). Dato che i chetoni acetoacetato e β-idrossibutirrato sono acidi, lo stato di chetosi implica 
una condizione di acidosi. Siccome il pH del sangue è 7,4 e la pKa dell’acetoacetato è 3,8 e quella del β-
idrossibutirrato è 4,8, questi acidi circolano nel sangue in forma dissociata e sono eliminati insieme agli ioni 
sodio e potassio (Siliprandi & Tettamanti 2011) . Questa perdita di cationi porta una diminuzione del pH che 
viene normalmente tamponata dal corpo tranne quando l’assunzione di sodio e potassio è impedita (Phinney 
2004) oppure in caso di diabete scompensato, quando c’è una sovrapproduzione di corpi chetonici con livelli 
superiori a 20 mmol/L e conseguente riduzione del pH. Il biochimico Hans Krebs fu il primo a distinguere la 
chetosi fisiologica da quella patologica (Krebs 1966). Per i muscoli scheletrici e cardiaco, che utilizzano 
normalmente i grassi, l’utilizzo dei corpi chetonici a scopo energetico è un vantaggio relativo, mentre per il 
sistema nervoso centrale, in cui l’accesso degli acidi grassi è impedito dalla barriera ematoencefalica, la 
disponibilità dei corpi chetonici è un importante surrogato del glucosio, che è il substrato abituale dei neuroni. 
Durante il digiuno, in dieta chetogenica e nei neonati, il cervello utilizza i corpi chetonici come combustibili 
principali al posto del glucosio (Laeger, Metges et al. 2010), proporzionalmente al grado di chetosi (Hartman, 
Gasior et al.). Il β-idrossibutirrato è il principale corpo chetonico circolante e il suo trasporto attraverso la 
barriera ematoencefalica avviene sia mediante diffusione che attraverso i trasportatori MCT1 e MCT2, dei quali i 
primi aumentano durante una dieta chetogenica (Newman, Verdin 2014). Quest’azione complementare tra il 
fegato, che produce i corpi chetonici in assenza di carboidrati, e il sistema nervoso centrale che li può utilizzare, 
è un evento molto importante che fu determinante per la sopravvivenza della specie umana nei millenni. 
 
La mia ricerca si è focalizzata su tre importanti aspetti delle diete chetogeniche - connesse alla perdita di peso - 
che richiedevano di essere approfonditi: 
1. il mantenimento del peso perso dopo una dieta chetogenica: il mantenimento del peso perso a lungo nel 
tempo è impegnativo e la paura di ritornare velocemente al peso iniziale è comune, tanto che questo 
fenomeno viene chiamato “effetto yo-yo". A questo proposito, le diete a basso contenuto di carboidrati sono 
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note per portare risultati migliori rispetto alle diete a basso contenuto di grassi in termini di perdita di peso 
(Shai, Schwarzfuchs et al. 2008c), ma non di “compliance” (adesione al protocollo) (Greenberg, Stampfer et 
al. 2009). Recentemente, Sumithran e collaboratori hanno dimostrato che l'aumento dei livelli circolanti di 
grelina e del livello di appetito tipici di una dieta ipocalorica erano minori durante un protocollo chetogenico 
(Sumithran, Prendergast et al. 2013). Abbiamo quindi ipotizzato che alcuni aspetti della dieta chetogenica 
come il mantenimento della massa muscolare, del metabolismo energetico basale e la stabilità del principale 
ormone oressigenico (grelina) combinati con gli effetti benefici della nutrizione tradizionale mediterranea, 
potessero favorire la perdita di peso a lungo nel tempo. Lo scopo del nostro studio è stato quindi quello di 
indagare l'effetto sul peso e sulla composizione corporea di due brevi periodi di una dieta chetogenica 
modificata, cioè una dieta fitochetogenica mediterranea (KEMEPHY) (Paoli, Cenci et al. 2010a, Paoli 2011, 
Paoli 2012) intervallata da 2 periodi più lunghi di dieta di mantenimento basata sulla dieta mediterranea 
tradizionale per un periodo totale di 12 mesi. I soggetti reclutati erano obesi o in sovrappeso e lo studio è 
stato retrospettivo. Abbiamo analizzato 89 soggetti (uomini e donne) di età compresa tra i 25 e i 65 anni che 
erano in uno stato di buona salute generale benchè fossero obesi (IMC medio 35.82 ± 4.11 kg/m2). I risultati 
di questo studio hanno dimostrato che la maggioranza dei soggetti ha ottenuto una significativa perdita di 
peso (10%) a seguito delle due fasi di dieta chetogenica e l’aderenza al protocollo è stata alta sia durante i 
sei mesi di perdita di peso sia nei successivi sei mesi di mantenimento, senza riacquisto del peso. Inoltre, il 
protocollo proposto ha portato miglioramenti nella maggior parte dei soggetti dei livelli di parametri 
importanti per la salute (colesterolo totale, colesterolo LDL, trigliceridi e livelli di glucosio). L’alta 
“compliance” è stato un fattore determinante per i risultati ottenuti; 
2. la formulazione di nuovi prodotti a basso contenuto di carboidrati per sopperire alla mancanza del sapore 
dolce durante una dieta chetogenica: un aspetto delle diete chetogeniche difficile da tollerare nel lungo 
tempo, soprattutto per chi ha una spiccata preferenza per i dolci, è la mancanza di questo sapore. In dieta 
chetogenica è necessario mantenere un basso livello di glicemia (circa 80-90 mg/dL) per evitare i picchi di 
insulina (Paoli, Canato et al. 2011) e permettere così ai soggetti di migliorare l'ossidazione dei grassi come 
dimostrato da Paoli et al. (Paoli, Grimaldi et al. 2012) e da Tagliabue et al. (Tagliabue, Bertoli et al. 2012). 
Oggi la nuova tecnologia alimentare, che è in grado di costruire prodotti ultra-processati con un contenuto di 
zucchero molto basso e un alto contenuto di proteine e fibre, può aiutare a risolvere questo problema, 
formulando prodotti di elevata appetibilità in un formato pronto per il consumo, utili sia in chetosi che in 
diete ipoglucidiche più moderate. Di solito i prodotti ultra-processati mancano di proteine e fibre e 
producono picchi post-prandiali di glucosio e insulina (OPS WHO 2015) . Questo effetto provoca un forte 
desiderio di cibo con una preferenza per i carboidrati ad alto indice glicemico (Lennerz, Alsop et al. 2013), 
fenomeno definito come "carb-craving" (Ventura, Santander et al. 2014). Al fine di analizzare l'effetto di 10 
diversi alimenti ultra-processati ad alto contenuto proteico e basso contento di carboidrati sulla glicemia, 
abbiamo reclutato 14 donne sane e abbiamo testato la loro risposta glicemica attraverso il metodo del 
punteggio glicemico (“glucose-score”, GS). Tutti gli alimenti testati hanno prodotto, rispetto al glucosio, 
una risposta glicemica significativamente inferiore e il loro GS è risultato inferiore a 25 (rispetto al valore di 
riferimento del GS del glucosio che è 100). Abbiamo quindi concluso che la riformulazione di prodotti ultra-
processati pronti al consumo in una versione ad alto contenuto proteico e basso contenuto di carboidrati è in 
grado di produrre una risposta glicemica significativamente più bassa, pur mantenendo l'alto valore del 
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pratico formato pronto per l'uso e l'alta appetibilità richiesta dai consumatori, facilitando quindi l'adesione a 
una dieta chetogenica di individui che tendono ad avere una forte preferenza per i cibi dolci; 
3. l’effetto delle diete chetogeniche sulle funzioni cognitive: il range di variazione della glicemia o dei corpi 
chetonici nel sangue di soggetti non diabetici è ampia e ciascuno di essi può essere utilizzato come energia 
dal cervello. I dati sugli effetti della variazione dei livelli di glicemia e chetonemia sulle funzioni cognitive 
di esseri umani sani dopo diversi tipi di dieta sono scarsi. Lo scopo di questo studio è stato confrontare gli 
effetti della variazione di glicemia e chetonemia dopo dieci giorni di due differenti diete chetogeniche e di 
una dieta mediterranea ipocalorica (MD) sulla memoria di lavoro e sulle funzioni esecutive in 63 giovani 
donne sovrappeso, sedentarie e in buona salute (IMC> 25, età: 20-35) che sono state reclutate nella zona 
universitaria. I soggetti sono stati divisi in gruppi in base al giorno di inizio della loro fase follicolare per 
minimizzare gli effetti ormonali sull'umore e le misurazioni basali sono state effettuate cinque giorni prima 
dell'inizio del protocollo dietetico. I seguenti controlli sono stati fissati al giorno di inizio della dieta (t1), al 
terzo (t3), al quinto (t5), al settimo (t7) e all'ultimo giorno (t10). Al controllo iniziale è stato misurato il peso 
dei soggetti ed è stata eseguita un'analisi impedenziometrica. I soggetti hanno poi assunto una colazione ad 
alto contenuto di carboidrati e hanno completato i test psicologici. Al t1, T3, T5, T7 e t10 sono stati misurati 
il livello dei corpi chetonici e la glicemia, così come i livelli di appetito. Nel giorno dell'ultimo controllo 
(T10) i soggetti hanno ripetuto l'analisi impedenziometrica, la misura del peso corporeo e, dopo la colazione 
(ogni gruppo ha assunto una colazione diversa a seconda della dieta prescritta), hanno completato i test 
psicologici. I test psicologici consistevano in un test sull'umore, due compiti cognitivi, uno per indagare la 
memoria di lavoro (“visuo-spatial n back”) e uno per analizzare le funzioni esecutive (“inhibitory control 
task”) e in una scala VAS per testare il livello di appetito. 45 soggetti hanno completato lo studio. 
Considerando tutti i partecipanti insieme, i livelli di glucosio pre-dieta correlavano positivamente con il 
tempo di reazione nel “go-trial” del test delle funzioni esecutive (r(43) = 0,358, p = 0,018), ma questa 
relazione non è stata trovata nel post-dieta, sia quando i soggetti sono stati analizzati tutti insieme che 
quando i soggetti sono stati divisi in base al tipo di dieta seguita. Nello stesso test psicologico, nel post-dieta 
la misura della chetonemia ha mostrato una correlazione negativa con l'accuratezza ai compiti “no-go” 
(r(29) = -0,455, p = 0,027). Possiamo quindi concludere che giovani soggetti in sovrappeso con livelli di 
glicemia inferiori al livello di pre-diabete sono stati influenzati negativamente da una colazione ad alto 
contenuto di carboidrati nel corso di un test di funzioni esecutive. Inoltre, l'effetto di moderati livelli di corpi 
chetonici (2 ± 1,3 mmol / L) ha nfluenzato negativamente l'accuratezza nelle prove “no-go” del test sulle 
funzioni esecutive. 
 
Nella prima delle tre ricerche sopra descritte, che era retrospettiva, ho analizzato i dati e ho lavorato alla stesura 
dell'articolo. Nel secondo e terzo studio, che ho progettato e attivamente condotto sotto la supervisione del Prof. 
Antonio Paoli, ho gestito con cura tutti i passaggi, dal reclutamento e selezione dei soggetti all'analisi dei risultati 
e stesura degli articoli. Nel terzo studio, che è stato eseguito tra aprile 2015 e giugno 2016, Lisa Zarantonello, 
dottoranda in psicologia, si è occupata dei test psicologici. 
 
 
_________________________________________________________ 
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(English) 
Ketogenic diets (KDs) are diets in which the net carbohydrate intake, calculated by subtracting fibres from total 
carbohydrates, is between 20 and 50 g/day (<10% of total energy intake) with a variable proportion of proteins 
and fats (Noakes, Windt 2017). In these conditions, glycogen stores are depleted (Paoli, Canato et al. 2011), 
insulin level is low and energy metabolism is mainly dependent from fat oxidation. KDs lead a significant 
increase in circulating levels of ketone bodies (KBs) β-hydroxybutyrate (βOHB), acetoacetate (AcAc) and 
acetone (Veldhorst, Westerterp et al. 2010). While AcAc and βOHB are used as energy, acetone is a volatile 
compound and is eliminated through expiration, giving the “sweet” breath odour typical of ketosis, or via renal 
excretion (Paoli, Canato et al. 2011). The concentration of KBs in the blood of healthy individuals during the 
carbohydrate fed state is about 0.1 mmol/L and increases to about 0.3 mmol/L after an overnight fast, but after 
prolonged fasting up to 20 days KBs can increase to more than 10 mmol/L. A diet is considered “ketogenic” 
when produces a stable increase in the level of βOHB higher than 0.6 mmol/L (Wiggam, O'Kane et al. 1997) or 
when the molar ratio of blood glucose to blood ketone body βOHB is less than or equal to 1 (Meidenbauer, 
Mukherjee et al. 2015). Since KBs AcAc and βOHB are acids, the ketosis state implies a condition of acidosis. 
Given the fact that the pH of the blood is 7.4 and that the pKa of AcAc is 3.8 and that of βOHB is 4.8, these 
acids circulate in the blood in a completely dissociated form and are eliminated together with sodium and 
potassium ions (Siliprandi & Tettamanti 2011). This loss of cations implies a decrease of pH, which is normally 
balanced from the body apart when potassium and sodium intake are impaired (Phinney 2004) or in pathological 
overproduction of KBs during untreated diabetes type 1 which leads to diabetic ketoacidosis, characterized by a 
KBs level higher than 20 mmol/L with a decrease of pH. Biochemistry Hans Krebs was the first who diversified 
physiologic from pathologic ketosis (Krebs 1966). For skeletal and cardiac muscle, which usually oxidize fats, 
the use of KBs is a relative advantage, while for the central nervous system, in which the entrance of fatty acids 
is prevented from the blood-brain-barrier (BBB), the availability of KBs is an important surrogate of glucose, 
which is the habitual substrate of nervous tissue. During starvation, under a ketogenic diet or in new-born 
infants, the brain can utilize KBs as primary fuel instead of glucose (Laeger, Metges et al. 2010) in proportion to 
the degree of ketosis (Hartman, Gasior et al.). βOHB is the most abundant circulating ketone body and its 
transport across the blood-brain barrier is mediated both by diffusion and by several monocarboxylic acid 
transporters as MCT1 and MCT2, the former being upregulated during a ketogenic diet (Newman, Verdin 2014). 
This complementary action between the liver, which produces KBs in periods of shortage of carbs, and the CNS 
which use them, it’s a very important event which was determinant for the survival of the human species over 
the millennia. 
 
My research focused on three important aspects of KDs and weight loss, which needed further investigation:  
1. long-term successful weight loss after a KD: the maintenance of weight loss over long time is challenging 
and the fear of weight regain is common, so that this phenomenon is named “yo-yo” effect. In this regard, 
low-carbohydrate diets are known to bring better results compared to low-fat diets in terms of weight loss 
(Shai, Schwarzfuchs et al. 2008) but not of compliance (Greenberg, Stampfer et al. 2009). Recently, 
Sumithran and colleagues have demonstrated that the increase in circulating ghrelin and in subjective 
appetite, which accompanied a hypocaloric diet, was reduced with a ketogenic approach (Sumithran, 
Prendergast et al. 2013). Thus, we hypothesized that certain aspects of the KD such as muscle mass 
retention, RMR (resting metabolic rate) and orexigenic hormone stability combined with the acknowledged 
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health benefits of traditional Mediterranean nutrition may favour long-term weight loss. The aim of our 
study was to investigate the effect on weight and body composition of two short periods of a modified KD, 
i.e., a very low carbohydrate ketogenic diet with phytoextracts (KEMEPHY) (Paoli, Cenci et al. 2010, Paoli 
2011, Paoli 2012)  interspersed between longer periods of maintenance nutrition, based on the traditional 
Mediterranean diet, over a total period of 12 months in obese/overweight healthy subjects and was designed 
as a retrospective study. We analysed 89 male and female subjects, aged between 25 and 65 years who were 
overall healthy apart from being obese (mean BMI 35.82 ± 4.11 kg/m2). Data from this study demonstrate 
that the majority of subjects showed significant weight loss (10%) as a result of a two-phase KD and were 
compliant both during the six month weight loss phase and the six month normocaloric maintenance phase, 
with no weight regain. Moreover, the proposed protocol led improvements in health risk factors (total 
cholesterol, LDL cholesterol, triglycerides and glucose levels) in the majority of subjects. Compliance was 
very high which was a key determinant of the results seen;  
2. formulation of new low-carbohydrate ultraprocessed foods to overcome the lack of sweet taste during a KD: 
a point of interest, which has always been a detrimental aspect of KDs, is the lack of sweet taste, which 
could be difficult to sustain for long periods, especially for people with a high sweet food preference. 
During consumption of a KD, it is mandatory to maintain a low level of glycaemia (about 80–90 mg/dL) to 
avoid insulin spikes (Paoli, Canato et al. 2011). This condition allows subjects to improve their fat oxidation 
as demonstrated by Paoli et al.  (Paoli, Grimaldi et al. 2012)  and by Tagliabue et al. (Tagliabue, Bertoli et 
al. 2012). Today the new food technology, which is able to build ultra-processed products very low in sugar 
content and high in protein and fibres, can help to solve this problem, formulating products with a high 
palatability and ready-to-consume format, useful both in ketosis and in easier low carb diets. Usually, ultra-
processed products lack in proteins and fibres and produce postprandial glucose and insulin spikes (PAHO 
WHO 2015). This effect is known to elicit food craving and overeating, with a preference for high-
glycaemic index carbohydrates (high-GI CHO) (Lennerz, Alsop et al. 2013), a phenomenon defined as 
CHO-craving effect (Ventura, Santander et al. 2014). In order to analyse the effect of 10 different high-
protein low-CHO proprietary foods on glycaemia, we recruited 14 healthy females, which were tested for 
their glycaemic response through the glycaemic score (GS) method. All test foods, compared with glucose, 
produced a significantly lower glycaemic response and their GS resulted lower than 25 (compared to the 
reference GS value of glucose which is 100). We concluded that the reformulation of ultraprocessed ready-
to-consume foods in a low-CHO, high-protein version can produce a significantly lower glycaemic response 
whilst maintaining the valued ready-to-use format and high palatability demanded by consumers, facilitating 
the adherence to a KD of individuals who tend to have a high preference for sweet foods; 
3. effect of KDs on cognitive functions: the range of variation of glucose and ketone bodies (KBs) in the blood 
of non-diabetic individuals is wide and both of them can be used as energy from the brain. Data on 
glycaemia and ketonemia effects on cognitive functions on healthy humans following different diets are 
scarce. The purpose of this study was then to compare the effects of glycaemia and ketonemia variation after 
ten days of two different ketogenic diets and a calorie-restricted Mediterranean diet (MD) on working 
memory and executive functions in 63 sedentary healthy overweight (BMI>25) young women (age: 20-35), 
which were recruited in the university area. Subjects were divided in groups according to the day of the 
beginning of their follicular phase in order to minimize hormonal effects on mood and came for the basal 
measurements five days before the start of the dietary protocol. The following controls were set on the 
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starting day of the diet (t1), on the third (t3), on the fifth (t5), on the seventh (t7) and on the last day (t10). 
On the basal control day, the weight of the subjects was measured and a body impedance analysis was 
performed. Subjects took a standard high carb breakfast and afterwards they completed the psychological 
tests. At t1, t3, t5, t7 and t10 ketone bodies levels and glycaemia were measured, as well as appetite levels. 
On the last control day (t10) subjects repeated the body impedance analysis, the body weight measure and, 
after breakfast (each group had a different breakfast according to the prescribed diet), the psychological 
tests. Psychological tests consisted in a mood test, two cognitive tasks, one to investigate working memory 
(visuo-spatial n back) and the second to stress executive functions (inhibitory control task) and in a VAS 
scale to test the appetite level. 45 subjects completed the study. Considering all participants together, pre-
diet glucose levels were positively correlated with reaction time in the go-trial of the executive function test 
(r(43) = 0.358, p = 0.018), but this relation was not found in the post-diet measure both when subjects were 
analysed all together and when subjects were divided according to the type of diet followed. In the same 
psychological test, in the post-diet measure ketonemia showed a negative correlation with accuracy of the 
no-go trials (r(29) = -0.455, p = 0.027). We can conclude that healthy young overweight subjects with 
fasting glycaemia below prediabetes level were negatively affected by a high-carb breakfast during an 
executive function test. Moreover, the effect of mild KBs levels (2 ± 1.3 mmol/L) negatively affected 
accuracy of the no-go trials of the executive functions test. 
 
In the first of the three above-described researches, which was retrospective, I analysed the data and worked on 
the drafting of the article. In the second and the third scientific works, which I designed and actively conducted 
under the supervision of Prof. Antonio Paoli, I carefully managed all the procedures, from the selection and 
recruitment of subjects to the analysis of the results and the writing of the articles. In the third study, which has 
been conducted between April 2015 and June 2016, Lisa Zarantonello, PhD student of psychology, guided the 
psychological tests.  
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INTRODUCTION 
 
Facing globesity 
The World Health Organization defines overweight and obesity as “abnormal or excessive fat accumulation that 
presents a risk to health” (WHO 2016).  
 
Overweight and obesity are determined through several methods of which three are the most used during normal 
clinical practice: body mass index (BMI), plicometry and bioelectrical impedance (Deurenberg, Yap 1999). 
BMI, also known as “Quetelet index” is the most widely used since it is the same for both sexes and for all ages 
of adults and it is calculated by dividing the weight of the subject in kilograms for the square of his height in 
meters. A BMI greater than 25 Kg/m2 is a sign of overweight, whereas a BMI greater than 30 Kg/m2 of obesity. 
 
Despite the interest of the scientific world for obesity began to germinate in the early 70s in both Europe and 
United States, we have to wait the 1995 and the birth of the International Obesity Task Force (IOTF) by 
Professor Philip James for a global awareness on the gravity and consequences of this phenomenon (World 
Obesity Federation 2015). The IOTF was born with the purpose of conducting the first scientific research on this 
subject, involving experts from around the world and drew the first global report on the epidemic of obesity. 
In 1997, following the path traced by this first initiative, it was organized in Geneva the first meeting of World 
Health Organization experts on this issue and in 2000, with the publication of the WHO Technical Report Series 
894 entitled Preventing and Managing the Global Epidemic, obesity was defined as a "worldwide epidemic 
disease" associated with serious health consequences (Consultation 2000). 
Today overweight and obesity are social issues, spreading in both high income and low income countries and 
have been analysed by two opposing views: one individualistic which considers the individual the responsible 
and one systemic, which discharges the responsibility on the environment and social factors. Both points of view 
can, however, be useful to understand the evolution of the obesity epidemic. On one hand the individual is 
responsible for his health, on the other hand the environmental factors may influence the individual's ability to be 
so. The individual and the environment interact reciprocally: if the environment provides copious amounts of 
unhealthy food, the individual will modify his food choices eating a higher amount of it.  
Food companies manipulate the ingredients of food products generating ultra-processed products to maximize 
the pleasure of consumers. Salt, sugar, fats and various food additives become the main ingredients of these 
foods, causing, in those eating them, neurobiological changes similar to those of psychoactive substances (Davis 
2014). Such foods are also very low in fibres and proteins, essential elements of healthy nutrition, which help to 
increase the feeling of satiety (Pesta, Samuel 2014, Clark, Slavin 2013). 
Exposure to these "altered" tastes is of particular concern for children, because childhood is the period of life in 
which there is a greater preference for sweet taste (Ventura, Mennella 2011). The child, easily impressed by the 
food marketing, develops a preference for ultra-processed foods due to both the strong image component that 
accompanies these products and to the pleasant taste and particular brain neurochemistry generated by their 
repetitive intake. From the sale of ultra-processed foods, high in energy but lacking in nutrients, industries earn 
huge profits. This creates a vicious cycle that could be broken only by government intervention, but such 
intervention are impeded by great obstacles like the lobby of the industries, the inability of governments to 
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implement these policies and the lack of social pressure for a political action against it (Roberto, Swinburn et al. 
2015). 
Published data (Ng, Fleming et al. 2014) report that the global percentage of adults with a BMI greater than 25 
has increased from 1980 to 2013 from 28.8% to 36.9% in men and from 29.8% to 38.0% in women. Children 
and teenagers are not immune to this phenomenon and recorded an increase in obesity with a prevalence of 23% 
in developed countries and 13% in developing countries. Despite the awareness of the gravity of this epidemic 
and of its impact on health and welfare, no country has been able, over the last 30 years, to address and reverse 
this phenomenon (Kleinert, Horton 2015).  
Regarding Europe, the prevalence of obesity and overweight has tripled from 1980 to 2015 and continues to 
increase, especially among children. The European Office of the World Health Organization has therefore 
established an initiative (COSI, Childhood Obesity Surveillance Initiative) to monitor the weight trends in 
children between 6 and 10 years (Wijnhoven, van Raaij et al. 2014). 
 
Overweight and obesity are also important modifiable risk factors to prevent the development of both non-
communicable diseases (NCDs) and metabolic syndrome (MetS). 
NCDs, such as diabetes, cardiovascular disease, various cancers and chronic lung disease, account for 63% of 
annual global deaths, equivalent to more than 36 million deaths per year of which 17.5 million are caused by 
cardiovascular disease, 8.2 million by cancer and 1.5 million by diabetes (WHO Fact Sheet on 
Noncommunicable diseases 2015). Regarding health care costs, NCDs have a global cost of 6.3 trillion dollars 
(US $), which is expected to rise to 13 trillion (US $) by 2030 (Arena, Guazzi et al. 2015). For this reason, the 
World Health Organization Plan for the Prevention and Control of Non-communicable Diseases 2013-2020 
targets to avoid any increase in obesity prevalence between 2010 and 2025.  
The MetS is the simultaneous presence of at least 3 of the following 5 risk factors: a large waistline, a high 
triglyceride level, a low HDL cholesterol level, high blood pressure and high fasting blood sugar (U.S. 
Department of Health and Human Services 2016). Even if reading the above current definition could seem that 
the risk factors are separated from each other, Jeff Volek and colleagues showed that there is an underlying 
effect in MetS, which is the resistance to the action of insulin in peripheral tissues that manifests itself as 
hyperglycaemia, hyperinsulinemia, and atherogenic dyslipidemia (high TG, low HDL-C, and small LDL-C) 
(Volek, Fernandez et al. 2008).  
 
The World Health Organization defines overweight and obesity as “largely preventable” but, in order to 
implement an effective prevention plan, it is essential to understand their origin (WHO 2016). Until now this has 
not be established, since the aetiology of these disorders is complicated by multiple links to genetic, social, 
economic as well environmental factors (Mutch, Clement 2006). However, based on most recent evidence, 
overweight and obesity could be seen principally as a marker of a high carbohydrate diet in someone who 
developed a disorder of carbohydrate metabolism (namely insulin resistance) (Reaven 2012, Mark, Du Toit et al. 
2016) and an effective strategy to prevent weight gain should then be that diet which is effective in minimizing 
insulin secretion at all times in those with insulin resistance (Prof. Tim Noakes, Jonno Proudfoot et al. 2015). 
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Nutritional approaches to overweight and obesity 
 
Besides preventing the onset of overweight and obesity, it is also important to have the right tools to manage 
weight loss. Literature data show that the combination of diet plus exercise is more effective than both diet-only 
and exercise-only interventions to achieve weight loss in overweight and obese people (Chin, Kahathuduwa et al. 
2016). However, despite the science of modern nutrition developed in the early 20th Century and several 
comparative studies were undertaken to determine the differences between diets (Phinney 2004), there is still no 
definitive data about which is the best dietary protocol in both the short and long term (Paoli 2014). An ideal 
weight loss diet would assure a high level of satiety, positive mood, the loss of fat mass together with the 
subsistence of metabolically active fat-free mass and the maintenance of weight loss over long time. 
 
Before analysing the different types of weight loss diets, let’s face two important aspects of modern nutrition: 
1. current nutritional guidelines profess that carbohydrates are the essential energy nutrient in the modern 
diet and should provide between 45 and 60% of the daily energy intake in all humans at all ages 
(Società Italiana di Nutrizione Umana - SINU 2014, WHO Regional Office for Europe ). However, it is 
interesting to note that humans have no essential requirement for carbohydrate and there is no known 
human carbohydrate deficiency disease (CDC Centers for Disease Control and Prevention 2014). 
Moreover, pure hunting cultures of indigenous people like the Inuit of the Canadian Alaskan Artic 
regions made at most seasonal use of this nutrient class, thus maintaining a functional well-being 
(Phinney 2004); 
2. for over a century the application of the first law of thermodynamics, also known as the law of 
conservation of energy, has governed nutrition. Observing this concept, the US Department of 
Agriculture concluded that all low-calorie diets lead an effective weight loss, regardless of 
macronutrient composition (Paoli, Rubini et al. 2013). 
But calories are really all the same? In laboratory conditions yes: 100 calories of spinach are equivalent 
from an energy point of view to 100 calories of sugar, but in the human body has been shown that it is 
not like this and that the law of conservation of energy is not suitable to describe the metabolism of 
nutrients in our bodies (Fine, 2004). The effects of same caloric intakes on weight and metabolism are 
different depending on the quantity and quality of protein, carbohydrates, fat, fibres and nutrients 
contained in the food we ingest (Li, Song et al. 2010, Wien, Sabate et al. 2003). This has led to the 
formulation of a new paradigm in nutrition based on the metabolic effect of carbohydrates: since it is 
known that they trigger the release of insulin and that this hormone has an anabolic effect leading to fat 
accumulation and weight gain, this theory has been named “carbohydrate-insulin model of obesity”. As 
a results, the use of low-carbohydrate diets has been suggested in order to avoid this effect and stimulate 
fat loss through the increase of the mobilization of free-fatty acids from adipose tissue and their 
subsequent oxidation. This theory has recently been challenged in studies conducted in metabolic 
wards, which tested isocaloric diets with different ratio between fat and carbohydrates but with equal 
amounts of proteins. Interestingly, results failed to show any increase in body fat loss following the 
low-carbohydrate compared to the high-carbohydrate diets, with variable results on total body weight 
loss (Hall, Chen et al. 2016, Hall, Bemis et al. 2015). These data, disrupting both the “old” paradigm of 
nutrition governed by the first law of thermodynamics and the “new” one governed by insulin, add new 
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material to the hot topic of nutrition “is a calorie a calorie?” and could suggest that, in nutrition, just one 
paradigm doesn’t fit all. Ad-hoc modifications of the new insulin-model of obesity could lead the 
chance to apply it only on certain groups of people, for example on those who show carbohydrate 
intolerance (Prof. Tim Noakes, Jonno Proudfoot et al. 2015, Hall 2017). 
 
In free living conditions, where diet adherence is the main determinant for fat loss, the most used weight loss 
diets are the energy restricted “balanced diets” (i.e. the Mediterranean diet), the low-fat/high-carbohydrate diets 
(FAT < 30 % of energy intake) where the reduction of total fat should lead to an appreciable effect of total 
caloric intake (Tobias, Chen et al. 2015) and the high-protein low-carbohydrate diets (HPLCDs) (4% < CHO < 
50% of energy intake; 20% < P < 40% of energy intake)  (Veldhorst, Westerterp et al. 2010, Soenen, Bonomi et 
al. 2012) which can be built with or without total energy restriction (Soenen, Bonomi et al. 2012, Veldhorst, 
Westerterp et al. 2010, Shai, Schwarzfuchs et al. 2008, Shai, Schwarzfuchs et al. 2008). Among HPLCDs there 
are the ketogenic diets (KDs), which will be discussed extensively in the next chapters.  
Nowadays there is a strong scientific support showing that HPLCDs lead to better results in both short and long 
term compared to higher carb or lower fat diets (Kris Gunnars 2014), while that favouring the low-fat diet is in 
rapid retreat (Nina Teicholz 2014). 
 
“Americans have dutifully followed official dietary advice to restrict fat and animal products for more than sixty 
years now, ever since the AHA first recommended this diet in 1961 as the best way to avoid heart disease and 
obesity. (...) Every reliable indicator of good health is worsened by a low-fat diet. (...) In the end what we believe 
to be true – our conventional wisdom – is really nothing more than sixty years of misconceived nutritional 
research. Before 1961, there were our ancestor, with their recipes. And before them were their ancestors with 
their hunting bows or traps or livestock – but like lost languages, lost skills and lost songs, it takes only a few 
generations to forget”  (Nina Teicholz 2014, pp.326-330) 
 
However, recent data show that it could be the higher-protein and not the low-carb content the main determinant 
of weight and body fat loss (Soenen, Bonomi et al. 2012) of HPLCDs, probably because of both the high 
thermogenic action (Leidy, Clifton et al. 2015, Wycherley, Moran et al. 2012) and the good satiating effect of 
this macronutrient. Studies report three main mechanisms involved in the latter effect:  
1. the increase of anorexigenic neuropeptides secreted by the intestinal tracts such as incretin 
hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-
1), cholecystokinin (CCK), peptide YY (PYY) and pro-opiomelanocortin (POMC) (Pesta, Samuel 
2014) ; 
2. the decrease of the orexigenic neuropeptide ghrelin (Pesta, Samuel 2014b, Wyka, Malczyk et al. 
2015); 
3. the increase of circulating levels of aminoacids that, according to the "aminostatic hypotesis" of 
1956, decrease hunger (Pesta, Samuel 2014). 
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Behind the scenes of ketogenic diets 
Among the low-carb/high-protein diets are found the ketogenic diets (KDs) in which the net carbohydrate intake, 
calculated by subtracting fibres from total carbohydrates, is between 20 and 50 g/day (<10% of total energy 
intake) (Noakes, Windt 2017). KDs lead, compared to HPLCDs, a greater reduction in appetite, a greater 
reduction in respiratory quotient, which is indicative of increased fat consumption at rest, and a significant 
increase in circulating levels of ketone bodies (KBs) β-hydroxybutyrate (βOHB), acetoacetate (AcAc) and 
acetone (Veldhorst, Westerterp et al. 2010). A diet is considered “ketogenic” when produces a stable increase in 
the level of βOHB higher than 0.6 mmol/L (Wiggam, O'Kane et al. 1997) or when the molar ratio of blood 
glucose to blood ketone body βOHB is less than or equal to 1 (Meidenbauer, Mukherjee et al. 2015). Based on 
this definition, diets with less than 38% of energy intake from carbohydrates can be considered ketogenic, since 
they can bring a mild elevation of KBs (Veldhorst, Westerterp et al. 2010). 
 
Originally, the classic KD was introduced at the Mayo Clinic in 1921 by Dr. Wilder as a starvation-mimicking 
diet to treat epilepsy (Hartman, Gasior et al. 2007), since starvation showed antiepileptic activity known from 
ancient time and described also in the New Testament of the Christian biblical canon (Matteo 17:14-21) (Paoli, 
Rubini et al. 2013). Dr. Wilder first described the most studied KD for epilepsy, which had a 4:1 ratio between 
long-chain fat content and carbohydrate plus protein combined (Hartman, Gasior et al. 2007). In 1925 Peterman 
at the Mayo Clinic designed the first KD for children, composed by 1g of protein per kilogram of body weight, 
10-15 g of carbohydrates per day and the reminder calories in fat (Wheless 2008).   
Even there isn’t any “official” formulation for the KD (Zupec-Kania, Zupanc 2008), in the classic antiepileptic 
KD calories are restricted (-25%) and fat, protein and carbohydrates are the 85%-90%, 15% and 5% respectively 
of total calories intake and the level of ketonemia can reach levels of 12 mmol/L (Bouteldja, Andersen et al. 
2014). In this diet the consumption of low carbohydrate proprietary foods is not common (Kossoff, Cervenka et 
al. 2013), whereas the intake of high fat foods such as whipping cream, butter and vegetables oil is 
recommended (Zupec-Kania, Zupanc 2008). Several concerns are related to the long term management of this 
diet despite the high level of ketosis achieved and the high antiepileptic effect, since the micronutrient content of 
the classic KD has proved to be deficient for calcium, vitamin D, phosphorus and magnesium (Zupec-Kania, 
Zupanc 2008). Moreover, the volume of fluid intake must be adapted to avoid dehydration, which could enhance 
adverse effects such as constipation and kidney stones (Zupec-Kania, Zupanc 2008). After the discover of 
antiepileptic drugs, the ketogenic strategy was abandoned to be re-discovered only in recent years after the first 
multicentre prospective study of the efficacy of the KD supported by The Charlie Foundation in 1998 (Wheless 
2008).  
 
Meanwhile, KDs had been used for weight loss purposes since the 19th Century, when the surgeon Mr. William 
Harvey cured the obesity of the prosperous London undertaker William Banting with a diet very low in 
carbohydrate and high in fat with moderate protein content. Mr. Banting, thrilled with the results, published in 
1863 the Letter on Corpulence, Addressed to the Public to describe the miraculous diet (Figure 1).  
Subsequently, the german Dr. Wilhelm Ebstein became the principal advocate of the original Harvey/Banting 
diet, since Harvey, shunned by the medical community as he was unable to explain why its treatment was 
effective, changed the original diet, including more protein and less fat, an edit which Banting considered less 
effective than the original (fatter) version. Then, the Banting/Ebstein diet spread throughout Europe and was 
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initially promoted in the United State by Dr. William Osler, Professor of Medicine at John Hopkins University in 
Baltimore, Maryland, USA. He, in his iconic medical textbook published in 1982 The Principles and Practice of 
Medicine prescribed the Banting/Ebstein diet as the treatment for obesity (Prof. Tim Noakes, Jonno Proudfoot et 
al. 2015).  
KDs were then used for weight loss under the name of “high fat diets” even if the “high fat” definition was 
misleading, since the actual fat intake was comparable or lower than the usual daily fat intake, probably because 
a higher fat intake was a common suggestion for thin people to gain weight and for this reason avoided by 
subjects aiming for weight loss. Protein content didn’t change too, so the total caloric intake during “high fat 
diets” was commonly reduced (YUDKIN, CAREY 1960). “The inevitable effect of caloric reduction” was taken 
as the explanation of their efficacy, crushing any hypothesis of particular metabolic mechanisms related to this 
type of diets. The low-caloric intake couldn’t, however, explain the decrease of appetite related to high fat diets, 
which was debated and put in relation with a supposed directly proportional effect between diet-carbohydrate 
content, fat intake and weight gain (YUDKIN, CAREY 1960). 
However, the main idea of the new-born nutritional science was that carbohydrate was a necessary nutrient for 
optimum human health and function and this was determined through studies as that of 1939 conducted by two 
Danish scientists, Christensen and Hansen (Christensen, Hansen 1939) and that conducted by Kark et al. during 
the Second World War (Kark, Johnson et al. 1945) which proved the higher efficiency of a high carb diet in 
short-term tests of high intensity exercise. Moreover, with the discovery of muscle glycogen as the limiting fuel 
for high intensity exercise, common consensus was that humans were impaired if nourished with a low carb diet. 
Despite these data, others were favourable to the use of KDs and were supported by demographic evidence that 
whole populations of people lived for millennia with virtually zero carbohydrate intake without any apparent 
impediment  (Phinney 2004). In this regard one of the first document was that of Lt. Frederick Schwatka’s 
expedition in 1878-1880 to search the lost Royal Navy Franklin. In his travel diary, found only 85 years later, 
Schwatka described the transition state to a diet without carbohydrate intake using these words (Stackpole 1965): 
“When first thrown wholly upon a diet of reindeer meat, it seems inadequate to properly nourish the system, and 
there is an apparent weakness and inability to perform severe exertive fatiguing journeys. But this soon passes 
away in the course of two or three weeks.” This described for the first time the issue of the “keto-adaptation”, 
deepened later by the elegant studies of Cahill (Phinney 2004). Around 1910 the anthropologist Vilhjalmur 
Stefansson, ignoring previous works of Schwatka, entered the Artic to study the Inuit culture. He adapted to their 
nomadic lifestyle and to their diet consisting solely of the products of hunting and fishing. Back to the US, 
Stefansson wrote a book entitled Not by Bread Alone where he enthusiastically reported his experience and 
became the subjects of a year-long laboratory trial during which he avoided all forms of carbohydrates. Against 
expectations of scientists, who thought that he got sick from scurvy, Stefansson, despite a 4 kg of weight loss 
during the first month, completed the trial in perfect health. The fact that humans were capable of surviving 
eating only one food group, led to the misunderstanding that the Inuit’s diet was high in protein, while it was 
only a modest intake of protein, deriving between 80-05% of their dietary energy intake from fat  (Phinney 
2004). Stefansson’s experience inspired the birth of various diets low in carbohydrates, of which the most 
influential was that of Dr. Robert Atkins, published in 1972 (Prof. Tim Noakes, Jonno Proudfoot et al. 2015). In 
Dr. Atkins’ New Diet Revolution in the first phase of the protocol was a KD very low in carbohydrate (< 20/50 
g/day) without any restriction for carbs and proteins (Miller, Bertino et al. 2003) and without the mandatory 
consumption of fatty foods typical of the original KD (Kossoff, Cervenka et al. 2013). Atkins’s hypothesis to 
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explain the mechanism involved in the success of KDs for weight loss was that the body lost energy through 
excretion of ketone bodies (Atkins 1972). This book made KDs famous to lose weight and after that many others 
commercial protocols succeeded. Together with the lower intake of fats compared to the original KD, these 
protocols, among which the Dukan diet, focused on protein-component, since diets high in protein showed rapid 
weight loss (Wyka, Malczyk et al. 2015). KDs diets became therefore known as “protein diets”, loosing in their 
definition the term “ketogenic diets”, since this made concern among physicians because of a lack of knowledge 
about the physiological mechanisms involved (Paoli 2014). In these diets the level of ketosis was mild (around 
4-6 mmol/L (Bouteldja, Andersen et al. 2014)) compared with that following the classic high fat KD (Kossoff, 
Cervenka et al. 2013). However, also the “protein diets” definition for KDs was misleading, since the state of the 
art KDs are only relatively high in proteins with a daily amount of protein of about 1.2-1.5 g of protein per Kg of 
body weight (Paoli 2014). A diet is considered a “normal protein diet” with 1.00 g of protein per Kg of body 
weight (Schiavo, Scalera et al. 2016), whereas it is considered a “high protein diet” if protein content is higher 
than 1.6 g per Kg of body weight (Wiegmann, Zlomke et al. 1990). 
However, even if KDs were commonly not “high protein” diets, negative opinions were related to their long-
term adoption for fear of common hyper-proteins side–effects. The use and the success of KDs have therefore 
always been very linked to the common opinion, which has always lacked of precise information and was 
commonly against their use.  
 
Another point of interest, which has always been a detrimental aspect of KDs, is the lack of sweet taste, which 
could be difficult to sustain for long periods, especially for people with a high sweet food preference (Lodi, 
Karsten et al. 2016). Today the new food technology, which is able to build ultra-processed products very low in 
sugar content and high in protein and fibres, can help to solve this problem, formulating products with a high 
palatability and ready-to-consume format, useful both in ketosis and in easier low carb diets (Lodi, Karsten et al. 
2016). 
 
Modern era of KDs should then focus on both the quantity and type of proteins and fats as well as of fibres, 
water and micronutrients, not excluding the advantages brought by the new ultra-processed-very-low-
carbohydrates foods in order to avoid detrimental aspects of original KDs.  
 
 
Figure 1: Second edition of the Letter on Corpulence, Addressed to the Public  (Banting 1863) located in the archive of the 
Royal College of Surgeons of England.  
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What is ketosis?  
Ketosis is a physiological process, which allowed our ancestors to survive and to stay efficient even in case of 
famine or when the consumption of dietary carbohydrate was only opportunistic  (Phinney 2004, Paoli, Canato et 
al. 2011).  
After 2-3 days of fasting or drastically reduction of carbohydrate intake (under 20/50 g/day) glycogen stores are 
depleted (Paoli, Canato et al. 2011) and insulin level is low. In these conditions, energy metabolism is mainly 
dependent from fat oxidation. This implies an acceleration of the rate of production of Acetyl-CoA and its 
mitochondrial concentration becomes too high compared to that of its use in the Krebs cycle. In normal 
carbohydrate-fed conditions, in which the glycolytic pathway provides adequate amounts of pyruvate, this would 
be converting in oxaloacetate from pyruvate carboxylase activity (Figure 2). The activation of this enzyme by 
Acetyl-CoA would prevent its accumulation, favoring its conversion to citrate. In the liver and in condition of 
carbohydrate deficiency, pyruvate and oxaloacetate are essentially used in the gluconeogenesis for the 
maintenance of blood glucose, and then the excess of acetyl-CoA, coming from increased β-oxidation of fatty 
acids, is not properly placed in the Krebs cycle. In addition, the β-oxidation of fatty acids requires the 
availability of CoA, whose content in cells is extremely limited. The set of these metabolic events is responsible 
for the accumulation of acetyl-CoA in liver mitochondria and causes that the molecules of this metabolite react 
with each other to make available the CoA required to maintain an adequate rate of β-oxidation (Siliprandi & 
Tettamanti 2011) .  
This marks the beginning of the metabolic pathway of ketosis, which leads to the formation of ketone bodies 
(KBs) β-hydroxybutyrate (βOHB), acetoacetate (AcAc) and acetone (Figure 3). 
 
 
 
 
 
Figure  2. Krebs cycle (Wikipedia 2008). 
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The second reaction of the ketogenic pathway is catalysed by 3-hydroxy-3metylglutaryl-CoA (HMG-CoA) 
synthesis and it is precisely for its abundance in the liver that ketogenesis happens there. This reaction leads to 
the synthesis of HMG-CoA and is also present in the cytosol of liver cells, where it is used for the biosynthesis 
of cholesterol (Paoli, Canato et al. 2011). However, in hepatic mitochondria there is HMG-CoA lyase, which is 
not present in the cytosol and permits the synthesis of the firs keton body (AcAc). 
A little part of AcAc is also formed from direct hydrolysis of acetoacetyl-CoA. This deacylation process happens 
mainly in the kidneys which can, although in size far below the liver, build ketones, while the liver produces 
KBs only through the standard pathway (Figure 3). 
AcAc, which is the primary product of ketogenesis, is then transformed in βOHB and in a little amount of 
acetone, the third KB. βOHB needs to be converted to AcAc to be metabolized by tissues through the Krebs 
cycle and this process is not possible in the liver, which can’t use KBs due to a lack of a specific enzyme (Paoli, 
Canato et al. 2011). From hepatic cells KBs diffuse in the blood, which deliver them to the muscles, heart and 
brain where they are used as energy instead of glucose, and to the kidney which partially use them and partially 
eliminate them in the urine. 
While AcAc and βOHB are used as energy, acetone is a volatile compound and is eliminated through expiration, 
giving the “sweet” breath odour typical of ketosis, or via renal excretion (Paoli, Canato et al. 2011). 
The concentration of KBs in the blood of healthy individuals during the carbohydrate fed state is about 0.1 
mmol/L and increases to about 0.3 mmol/L after an overnight fast, but after prolonged fasting up to 20 days KBs 
can increase to more than 10 mmol/L.  
Figure  3. Ketogenesis pathway. The three ketone bodies (acetoacetate, acetone and β-hydroxybutyrate) are marked within 
an orange box (Wikipedia 2012).  
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Since KBs AcAc and βOHB are acids, the ketosis state implies a condition of acidosis. Given the fact that the pH 
of the blood is 7.4 and that the pKa of AcAc is 3.8 and that of βOHB is 4.8, these acids circulate in the blood in a 
completely dissociated form and are eliminated together with sodium and potassium ions (Siliprandi & 
Tettamanti 2011). This loss of cations implies a decrease of pH, which is normally balanced from the body apart 
when potassium and sodium intake are impaired (Phinney 2004) or in pathological overproduction of KBs 
during untreated diabetes type 1 which leads to diabetic ketoacidosis, characterized by a KBs level higher than 
20 mmol/L with a decrease of pH. Biochemist Hans Krebs was the first who diversified physiological from 
pathological ketosis  (Krebs 1966) (Table1). The wide range of possible KBs concentration in blood is similar to 
that of glucose and also in this case an extreme high level manifests itself in deleterious outcomes (Volek, 
Fernandez et al. 2008).  
For skeletal and cardiac muscle, which normally oxidize fats, the use of KBs is a relative advantage, while for 
the central nervous system, in which fats don’t have access due to the presence of the blood brain barrier (BBB), 
the availability of KBs is an important surrogate of glucose, which is the habitual substrate. During starvation, 
under a ketogenic diet or in new-born infants, the brain can utilize KBs as primary fuel instead of glucose 
(Laeger, Metges et al. 2010) in proportion to the degree of ketosis (Hartman, Gasior et al. 2007). βOHB is the 
most abundant circulating ketone body and its transport across the blood-brain barrier is mediated both by 
diffusion and by several monocarboxylic acid transporters as MCT1 and MCT2, the former being upregulated 
during a ketogenic diet (Newman, Verdin 2014). 
This complementary action between the liver, which produces KBs in periods of shortage of carbs, and the CNS 
which use them, it’s a very important event. The availability of KBs in extra hepatic tissues it’s a way to spare 
glucose. In fact, the higher production of acetyl-CoA determines a higher production of citrate which, in the 
cytosol, inhibits the activity of glycolysis (Siliprandi & Tettamanti 2011). 
Moreover, it was demonstrated that KBs are able to produce 25% more ATP than glucose or fatty acid (Volek, 
Fernandez et al. 2008), thanks to the high chemical potential of βOHB which leads to an increase of the ΔG0 in 
the hydrolysis of ATP (Paoli, Canato et al. 2011).  
Finally, glycaemia during the KD doesn’t fall under physiological range, since glucose, which is formed through 
the gluconeogenesis process from glycerol released from the lysis of triglycerides, is sufficient for the 
maintenance of euglycaemia (Paoli, Canato et al. 2011). 
 
 
Table 1.  Blood values of several substances during a standard diet, a ketogenic diet and during the diabetic ketoacidosis 
(Paoli, Canato et al. 2011). 
 
Blood values Standard diet Ketogenic diet Diabetic ketoacidosis 
Glucose (mg/dL) 80-120 65-80 > 300 
Insulin (µU/L) 6-23 6.6-9.4 ≈ 0 
KBs (mmol/L) 0.1 7/8 > 25 
pH 7.4 7.4 < 7.3 
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Ketogenic diets for weight loss: the inevitability of metabolism 
 
 “Everything should be made as simple as possible but not simpler”  
Albert Einstein 
  
In recent years grew a renewed scientific interest in understanding those metabolic mechanisms, previously 
suspected but never clarified (YUDKIN, CAREY 1960, Paoli, Canato et al. 2011), which could be the real 
reason behind the success of KDs in both in weight loss and in the control of the sense of hunger. 
Considering weight loss, authors explain the better efficacy of KDs through a possible application of the second 
(instead of the first) low of thermodynamics, which predicts the flow of reactions in accordance to the increase 
of the entropy and of the dissipation of energy. Authors in favour of this mechanism hypothesize that the use of 
protein as source of energy in KDs is an “expensive” process for the organism and that could lead to a waste of 
calories. In a KD our body needs 60-65 g of glucose daily for red cells and neurons, which is obtained for the 
minor part from gluconeogenesis by glycerol and for most from gluconeogenesis by food or tissue proteins 
(Paoli, Canato et al. 2011, Landau, Wahren et al. 1996). About 100 g of protein can produce 57 g of glucose, so 
110 g of proteins are needed to provide 60-65 g of glucose. Several authors have confirmed the role of energy 
loss for gluconeogenesis in KDs and the cost of this process has been estimated of about 400-600 Kcal/day.  
Another aspect to be kept into consideration is the specific thermogenic response to food. This parameter 
calculates the energy expenditure to absorb and metabolise nutrients. For example, if we hypothesize a diet of 
2000 Kcal/day with a Mediterranean percentage of carbohydrates, fat and proteins of 55:30:15 and we calculate 
its thermogenic effect (which correspond to an energy expenditure of 7%, 2.5% and 27% of total caloric intake 
brought by carbohydrates, fats and proteins respectively) calories actually available would be 1825.5. If we 
suppose to reduce the percentage of carbohydrates to 20% of total calories and to replace the removed calories 
with equal percentages of proteins and fats, we obtain another reduction of actually available calories of 80 Kcal. 
In this case, the actually available daily caloric intake would be of 1757 Kcal (so we “lost” 243 Kcal for 
thermogenesis). Finally, if we want to sharply reduce the total carbohydrates intake to about the 8% of total 
caloric intake, we would loose another 40 Kcal, reaching the final level of 1717.8 Kcal/day (Paoli, Canato et al. 
2011).  
To summarize, the hypothesized mechanisms for weight loss of KDs are, listed in order of available evidence, 
the following: 
1. increased of the energy demanding processes of gluconeogenesis and the thermic effect of proteins;  
2. increased fat oxidation and decreased lipogenesis through a strong action of KDs on hepatic gene 
expression (Volek, Fernandez et al. 2008);  
3. greater metabolic efficiency in consuming fats highlighted by the reduction in the resting respiratory 
quotient (RQ). The RQ represents the ratio between produced CO2 and consumed O2 (CO2/O2): RQ of 
sugars is 1, while for a mixture of fatty acids is 0.7 (Paoli 2014). 
Considering the reported food control effect, several mechanisms are possibly involved (Paoli, Bosco et al. 
2015): 
1. reduction in appetite due to the higher intake of proteins which show loss of appetite through several 
mechanisms (see page 14);  
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2. reduction of the orexigenic neuropeptide ghrelin (Hall, Bemis et al. 2015) and increase of the 
anorexigenic neuropeptide cholecystokinin (CCK) (Paoli, Bosco et al. 2015); 
3. a direct effect on appetite suppression of the ketone bodies and of circulating free fatty acids (Paoli, 
Bosco et al. 2015). 
Metabolic effects of ketogenic diets such as the increased fat oxidation and the decreased feeling of hunger give 
advantages to these diets compared to “balanced diets” proved in “real life” studies, which show a greater 
compliance and then a better weight and fat loss of KDs compared to “balanced diets” (Kris Gunnars 2014). 
Interestingly, these advantages seem to vanish in studies conducted in metabolic wards, where isocaloric high-
carbohydrate diets with equal amount of proteins proved equal or better results of high-carb diets compared to 
KDs in terms of fat loss or energy expenditure (Hall, Chen et al. 2016, Hall, Bemis et al. 2015).   
  
Pontential risks of ketogenic diets 
 
If we treat KDs as high protein diets, which is not fully correct, risks related to this approach would be those of 
an excess of protein intake. The most feared negative effect of high protein diets is the impairment of renal 
function with an increase in glomerular pressure and hyperfiltration (Wyka, Malczyk et al. 2015). However, data 
in this regard are not uniform and some claim that a high protein intake is not harmful to renal function which 
can adapt to it (Skov, Haulrik et al. 2002, Martin, Armstrong et al. 2005), while others support the prolonged use 
of KDs as a therapy for diabetic nephropathy in mice (Poplawski, Mastaitis et al. 2011). Another common side 
effect of high protein diets is the so called “rabbit malaise”, a typical Inuit’s malady of early spring when lean 
rabbits were the only available food, which is characterised by headache and lassitude (Phinney 2004). Finally, 
fatigue and apparent cardiac dysfunction were experienced in 1976 following the popular Liquid Protein Diet  
(Phinney 2004). However, KDs, as we previously discussed, are only “relatively” high in protein and therefore 
these risks are inconsistent.  
Regarding the feared risk of acidosis from hyperketonemia seen in untreated type-1 diabetes, such extreme 
ketone kevels (often above 20mmol/L) are caused by the absence of insulin and unregulated lypolisis and don’t 
appear in fasting or during carbohydrate restriction when ketone levels are controlled (always lower than 12 
mmol/L) (Volek, Fernandez et al. 2008) through regulatory mechanisms. Substrate availability for the ketogenic 
pathway is controlled both by the presence of insulin that impairs lipolysis and by KBs that act as feedback 
regulators. Moreover, βOHB itself stimulates beta-cell insulin release (Volek, Fernandez et al. 2008) while its 
production is limited through a feed-back regulation which prevents the excessive exhaustion of fat depots 
during prolonged starvation with action on GPR109A receptor, also known as niacin receptor (Laeger, Metges et 
al. 2010). Finally, the regulation of genetic expression of mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme 
A (HMG-CoA) synthase into mRNA has been studied as a control point in the ketogenic pathway (Casals, Roca 
et al. 1992).  
A lower bone density and a more intense onset of bone loss have also been related to the use of KDs. A study on 
bone mineral content of Alaskan Eskimos reported a normal bone growth among children, but a lower bone 
density and an earlier and more intense onset of bone loss after age 40 compared to citizens of the same age 
living in modernized and more sedentary USA. Whether it was the ketogenic state, a vitamin D deficiency and 
the decreased calcium absorption or the scarcity of alkalinizing fresh plant food that contributed to their earlier 
and faster bone loss is unclear (Mazess, Mather 1974). Another study tested the effect of 6 weeks of Atkins diet 
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and reported an increase of urine acidity and calcium excretion as well as a decrease of urinary citrate, an 
inhibitor of calcium stone formation. Researchers concluded that the Atkins diet “delivers a marked acid load to 
the kidney, increases the risk for stone formation, decreases estimated calcium balance, and may increase the 
risk for bone loss” (Reddy, Wang et al. 2002). Even if more studies are needed on long-term changes in bone 
mass or density, the intake of alkalinizing vegetables as well as a high fluid intake could be beneficial during 
KDs. 
Regarding cardiovascular disease and diabetes, there have been doubts about the safety of use of KDs: however, 
concerns about diabetes mostly appear as long-term conjectures not supported by data (Feinman, Pogozelski et 
al. 2015), whether those regarding cardiovascular disease are about their long-term safety and better efficacy 
compared to “balanced” diets  (Nordmann, Nordmann et al. 2006) and their risk related to the rise of blood 
cholesterol and triglycerides (Blackburn, Phillips et al. 2001). However, most recent works show a positive 
effect of KDs on this pathology (Volek, Phinney et al. 2009, Shai, Schwarzfuchs et al. 2008). Moreover, even if 
diabetes and cardiovascular disease have, until now, been treated separately, KDs show improvements in both 
conditions. According to the “Atherogenic Dyslipidaemia (AD)” theory, eating a high saturated fat diet causes 
increased LDL-cholesterol and triglycerides (TG), reduced HDL-cholesterol and arterial “clogging” and the 
suggestion to reduce saturated fat to prevent and to treat this condition is common (Volek, Fernandez et al. 
2008). However, data show that there is no definitive evidence that dietary animal (saturated) fat causes heart 
disease (Siri-Tarino, Sun et al. 2010). Moreover, the centenarian Dr. Fred Kummerow has spent 60 years 
showing how “oxysterols” (oxidized cholesterol) and not “cholesterol” is the real cause the development of 
arterial plaque (Kummerow, Cook et al. 2001). 
 
“Although the image of coronary arteries as kitchen pipes clogged with fat is simple, familiar, and evocative, it is 
also wrong” (Rothberg 2013) 
 
Recent evidences show that increased synthesis of larger triglycerides-enriched VLDL and of small LDL 
particles and reduced HDL-C are caused by a high carbohydrate diet (Volek, Fernandez et al. 2008) and that the 
TG/HDL ratio has been discovered to be the best predictor of insulin resistance and LDL particle diameter 
(McLaughlin, Reaven et al. 2005). Diabetes and coronary heart disease could then be seen as a unique disease a 
high carbohydrate (high fructose) diet with a low intake of omega-3 and a high intake of omega-6 produces toxic 
changes as increased glucose, insulin, triglycerides, small LDL-C particles, uric acid, CRP, decreased HDL-C 
and fatty liver (Lee, Min et al. 2016, Raatz, Johnson et al. 2015, Zock, Blom et al. 2016, Lin, Chan et al. 2016). 
In order to treat both conditions, the single most important intervention in the management of coronary heart 
disease and diabetes would be to reduce the amount of carbohydrate in the diet, since it is the only intervention 
that addresses all risk factors. With this reduction, glucose and insulin levels decrease and dietary fats would be 
processed very differently from the body (Volek, Fernandez et al. 2008). 
 
“The initial treatment for an abnormal carbohydrate/lipoprotein/inflammatory blood profile should be a high fat 
diet – not the use of statins which provide a marginal benefit in only 1 in 140 treated “healthy” subjects” 
(Abramson, Rosenberg et al. 2013) 
 
KDs are then supported by strong evidences for their therapeutic action in both diabetes (with a reduction of 
blood insulin levels and improvement of systemic insulin sensitivity) and cardiovascular risk parameters (with a 
reduction of total cholesterol and TG and an increase of HDL-C) (Volek, Fernandez et al. 2008, Paoli, Rubini et 
al. 2013). 
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EXPERIMENTAL PART 
___________________________________________ 
 
1. LONG TERM SUCCESSFUL WEIGHT LOSS WITH A COMBINATION 
BIPHASIC KETOGENIC MEDITERRANEAN DIET AND MEDITERRANEAN 
DIET MAINTENANCE PROTOCOL 
Paoli A, Bianco A, Grimaldi KA, Lodi A, Bosco G. Long term successful weight loss with a combination biphasic ketogenic 
Mediterranean diet and Mediterranean diet maintenance protocol. Nutrients, 2013. 
 
 
Introduction 
One of the major problems in weight control is the prevention of weight regain. Despite the majority of 
randomized controlled trials comparing ad libitum KDs with low-fat diets reported a greater weight loss over six 
months in the former (Nordmann, Nordmann et al. 2006, Shai, Schwarzfuchs et al. 2008, Schwarzfuchs, Golan et 
al. 2012), KDs are commonly criticized for the so called “yo-yo” effect or weight regain cycle (Jeffery 1996, 
Sumithran, Proietto 2013, Maclean, Bergouignan et al. 2011). 
Recently Sumithran and colleagues have demonstrated that the increases in circulating ghrelin and in subjective 
appetite, which accompanied a hypocaloric diet, were reduced with a ketogenic approach (Sumithran, 
Prendergast et al. 2013). Thus, we hypothesized that certain aspects of the ketogenic diet such as muscle mass 
retention, RMR (resting metabolic rate) and orexigenic hormone stability combined with the acknowledged 
health benefits of traditional Mediterranean nutrition may favour long term weight loss. The aim of our study 
was to investigate the effect on weight and body composition of two short periods of a modified ketogenic diet, 
i.e., a very low carbohydrate ketogenic diet with phytoextracts (KEMEPHY) (Paoli, Cenci et al. 2010, Paoli 
2011, Paoli 2012)interspersed between longer periods of maintenance nutrition, based on the traditional 
Mediterranean diet, over a total period of 12 months in obese/overweight healthy subjects. 
 
Subjects and Methods 
We designed this study as a retrospective analysis of the medical records of patients who began the weight loss 
intervention between 2006 and 2010 in selected medical centres. Patient charts were examined from the first  
clinical evaluation until after one year of dietary therapy supervised by a healthcare professional. The exclusion 
criteria from the baseline sample included: endocrine disease and cancer, which might induce weight variation, 
and severe mental illness. Inclusion criteria was BMI > 30, age between 25 and 65 years. Of 327 patients 
analysed, 89 obese subjects were selected that underwent a ketogenic Mediterranean diet with phytoextract 
(KEMEPHY), of these 81 fulfilled our inclusion criteria for this retrospective analysis: no use of antidepressant 
drugs, no diabetes and no change in quantity and quality of physical activity during the analysed time period. Of 
these 81 subjects, 68 completed the one year follow up protocol (84%). The general characteristics of the 68 
remaining subjects analysed were: age 49.17 ± 10 years, height 167 ± 10 cm, weight 100.67 ± 16.54 kg, BMI 
35.82 ± 4.11. All subjects were Caucasian (59 males, 12 females). During the first medical visit (t0) subjects 
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were educated on the KEMEPHY protocol and underwent anthropometric measurement, body composition and 
blood analysis. The year of treatment involved: 
• An initial 20 days of very low carbohydrate ketogenic diet (K1)  
• Followed by 20 days of a low carbohydrate non ketogenic diet (stabilization) (LC1) 
• A first period of 4 months of normalcaloric Mediterranean diet (M1) 
• A second 20 day very low carbohydrate ketogenic diet (K2)  
• 20 Days of low carbohydrate non ketogenic diet (LC2)  
• Final 6 months of normal caloric Mediterranean diet (M2)   
 
During the KEMEPHY period the subjects followed a commercially available protocol called TISANOREICA® 
(Paoli, Cenci et al. 2010a, Paoli 2011, Paoli 2012). Two weight loss intervention periods were used as previously 
available clinical data (unpublished) suggested that this was required to achieve a 10% weight loss. Subjects 
were analysed at seven time points: before starting the diet (t0), after K1 (t1), after LC1 (t2), after M1 (t3), after 
K2 (t4), after LC2 (t5) and after M2 i.e., approximately one year after first visit (t6) (Figure 1.1). All subjects 
gave their informed consent to data use and the study was approved by the Ethical Commission of the 
Department of Biomedical Sciences of the University of Padova. Efforts to maximize retention in the protocol 
included e-mail and telephone reminders for appointments and a weekly phone call to verify compliance.  
 
 
Figure 1.1. Experimental design: t0 = start (medical examination, anthropometric and body composition analysis, blood 
analysis); t1 = end of K1 (medical examination, anthropometric and body composition analysis); t2 = end of LC1 (medical 
examination, anthropometric and body composition analysis, blood analysis); t3 = start of K2 (medical examination, 
anthropometric and body composition analysis); t4 = end of K2 (medical examination, anthropometric and body composition 
analysis); t5 = end of LC2 (medical examination, anthropometric and body composition analysis); t6 = one year recall 
(medical examination, anthropometric and body composition analysis, blood analysis). VLCKD = very low carbohydrate 
ketogenic diet, LCD = low carbohydrate diet. 
 
Diet Protocols 
Each subjects received personal diet explanation by a qualified dietician during an individual visit. Dietary 
intake was measured with a validated 3-day food diary (Toeller, Buyken et al. 1997) and analysed by Dietnext® 
software (Caldogno, Vicenza, Italy). In the KEMEPHY protocol subjects almost totally exclude carbohydrates 
during the first three weeks. A detailed menu containing permitted and non-permitted foods was provided to 
each participant, along with the components of the ketogenic Mediterranean diet with phytoextracts. The diet 
consumed was primarily made of beef & veal, poultry, fish, raw and cooked green vegetables without restriction, 
cold cuts (dried beef, carpaccio and cured ham), eggs and seasoned cheese (e.g., parmesan). The drinks allowed 
were infusion tea, moka coffee and herbal extracts. The foods and drinks that subjects avoided included alcohol, 
bread, pasta, rice, milk, yogurt, soluble tea and barley coffee. In addition to facilitate the adhesion to the 
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nutritional regime, each subject was given a variety of specialty meals constituted principally of protein and 
fibers. These meals (TISANOREICA®, Asigliano Veneto, Vicenza, Italy) that are composed of a protein blend 
obtained from soya, peas, oats (equivalent to 18 g/portion) and virtually zero carbohydrate (but that mimic their 
taste) were included in the standard ration (Paoli 2011). During the KEMEPHY protocol, the subjects also 
consumed some specific herbal extracts useful to ameliorate the commonly reported symptoms of weakness and 
tiredness during the ketosis, improve glycaemic control and increase bile secretion helping digestion (choleretic 
effect)  (Paoli, Cenci et al. 2010, Paoli 2011) (herbal blends are described in tables 1.4 and 1.5). During the 
ketogenic diet periods, subjects assumed 1 caplet in of a multivitamin-mineral supplement each morning (Gaby 
2007, Zupec-Kania, Zupanc 2008, Phinney, Horton et al. 1980). Caplets (Multivitaminico Balestra e Mech, 
Gianluca MechSpA, Asigliano Veneto, Vicenza, Italy) contained Magnesium 19 mg, Calcium 16 mg, 
Phosphorus 8 mg, Zinc 4.5 mg, Iron 4.62 mg, Manganese 1 mg, Potassium 0.5 mg, Copper 0.4 mg, Chromium 
28.55 µg, Selenium 4 µg, Niacin 10 mg, Beta carotene 1.8 mg, Folic Acid 66 µg, Biotin 30 µg, Vitamin C 19.8 
mg, Vitamin E 3.3 mg, Pantothenic Acid 1.98 mg, Vitamin B6 0.66 mg, Vitamin B2 0.53 mg, Vitamin B1 0.426 
mg, Vitamin D3 1.65 µg, Vitamin B12 0.33 µg.  
During the months of the Mediterranean diet, subjects were instructed to follow a typical diet composed mainly 
of, whole grains (bread, pasta, whole wheat, rice), potatoes, meat, fish, eggs, poultry, vegetables, legumes, fruits, 
condiments (mainly olive oil), whole milk and wine. During the Mediterranean diet period the average 
macronutrients distribution was: 58% carbohydrate, 15% protein and 27% lipids (Kcal 1800 ± 108); the main 
sources of added fat were 30 to 50 g of olive oil per day (Shai, Schwarzfuchs et al. 2008). During the ketogenic 
period the prescribed daily intake of carbohydrate was about 30 g per day and the energy distribution of daily 
macronutrients was 12% carbohydrate, 36% protein and 52% lipids (Kcal 976 ± 118). During the low 
carbohydrate period the distribution was 25% carbohydrate, 31% protein and 44% lipids (Kcal 1111 ± 65) (Table 
1.1). 
Table 1.1. Characteristics of diets (data are expressed as mean and SD). 
 
Macronutrients Ketogenic phase Lowcarbohydrate phase Mediterranean phase 
Kcal/day 976 ± 118 1111 ± 65 1800 ± 248 
Protein (% total daily 
Kcal) 
41 ± 2 27 ± 2 15 ± 2 
Fat (% total daily Kcal) 46 ± 4 41 ± 2 27 ± 3 
Carbohydrate (% total 
daily Kcal) 
12 ± 2 33 ± 2 58 ± 4 
Protein (g/day) 100 ± 11 74 ± 11 67.5 ± 9 
Fat (g/day) 51 ± 9 50 ± 2 54 ± 6 
Carbohydrate (g/day) 30 ± 0.2 91 ± 5 261 ± 18 
 
 
Analysis 
Dietary intake was measured by validated 3-day food diary (Toeller, Buyken et al. 1997b, Black, Skidmore et al. 
2012) and analysed by Dietnext® (Caldogno, Vicenza, Italy) software. At each visit (timepoint t1–t6) subjects 
underwent anthropometric measurement, blood pressure measurements and body composition analysis, the latter 
 27 
was assessed using bioelectrical impedance analysis (BIA Akern Bioresearch, Pontassieve, FI, Italy) which is a 
non-invasive and portable method for the estimation of fluid compartments, fat and fat-free mass in healthy 
subjects. Bioelectrical impedance analysis was chosen because it is a reliable method and its safety, convenience 
and non-invasive nature makes it useful procedure to be deployed in the routine monitoring of body composition 
also during the ketogenic diet (Piccoli, Brunani et al. 1998, Saunders, al-Zeibak et al. 1993). At t0, t3, and t6 
fasting venous blood samples were collected at weeks 0 and 6 for total cholesterol (CHOL-T), triacylglycerol 
(TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), glucose, 
blood urea nitrogen (BUN), uricemia, eythrocyte sedimentation rate (ESR), creatinine, alanine transaminase 
(ALT), aspartate transaminase (AST), gamma-glutamyl transpeptidase (GGT). Blood was collected in EDTA 
treated vacutainer tubes. All measurements were made on a ROCHE/HITACHI 912, (Roche Diagnostics Ltd., 
Basel, Switzerland). Fasting total cholesterol was measured with an enzymatic colorimetric method. HDL-C and 
LDL-C were measured by an enzymatic colorimetric test in homogenous phase. Triglycerides with an enzymatic 
colorimetric TRINDER modified final point method. Plasma glucose was determined with the plasma glucose 
GOD-PAP enzymatic colorimetric method. Plasma urea nitrogen was measured using UV kinetic test. ALT and 
AST with IFCC enzymatic kinetic method. GGT with the SZASZ (kinetic photometric method), colorimetric 
method. Creatinine was measured using the JAFFE method with compensation, kinetic colorimetric test, and uric 
acid was determined using an enzymatic colorimetric method. 
 
Statistical Analysis 
The effect of the diet intervention was assessed using one way repeated-measures ANOVA. For body weight and 
fat percentage the measurements at t0, t1, t2, t3, t4, t5 and t6 were considered. For blood variables only t0, t3 and 
t6 time points were taken into account. When significant effects were found, post hoc analysis was performed 
using Tukey’s test. An alpha level of p < 0.05 was used to denote a significant effect. Kolmogorov-Smirnov tests 
were used to assess the normality of the data. Mauchley’s test of sphericity assessed the homogeneity of variance 
for the data. All statistical analyses were performed using the software package GraphPad Prism version 6.00 for 
Mac (San Diego, CA, USA). Values are represented as means and standard deviation (SD). 
 
Results 
There was a significant decrease in body weight after the first ketogenic period (p < 0.0001 t0 vs. t1); there was 
no significant difference between t1 and t2 nor between t2 and t3. At t4 body weight was significantly decreased 
compared to t3 and t1 (p < 0.01 and p < 0.001 respectively) after which it stabilized with no further significant 
changes at t5 and t6 (see Figure 1.2 A and Table 1.2). The same pattern was seen also for body fat percentage 
(see Figure 1.2 B and Table 1.2). Comparing bodyweight and body fat at t6 with t0 revealed that after one year 
there was an overall significant decrease in both parameters with no signs of weight regain over the course of the 
study. Systolic blood pressure showed a significant decrease comparing t0 vs. t2 (from 125 ± 10 to 117 ± 6 p < 
0.01) whilst there was a decrease albeit not significant of diastolic blood pressure (from 86 ± 5 to 82 ± 8). 
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Table 1.2. Changes in body weight and body fat percentage during one year diet protocol. Values are expressed as mean and 
standard deviation. Significance was reported in Results section. 
Anthropometric 
Data 
t0 t1 t2 t3 t4 t5 t6 
Body weight (kg) 100.7 ± 16.54 93.34 ± 15.04 90.33 ± 13.57 91.81 ± 12.58 86.64 ± 10.56 84.2 ± 10.04 84.59 ± 9.71 
% Body fat 43.44 ± 6.34 36.93 ± 6.49 36.26 ± 6.46 37.15 ± 6.82 34.46 ± 6.3 33.50 ± 6.18 33.63 ± 7.6 
 
 
Figure 1.2. Changes in body weight (A) and fat percentage (B) from baseline to month 12. Error bars indicate standard error 
of the mean. 
 
Blood measurements (Table 1.3) revealed a significant decrease in total cholesterol at t2 (p < 0.0001) vs. t0, 
followed by non-significant differences between t2 and t6 and a significant decrease comparing t6 with t0 (p = 
0.0003). HDL-C showed a significant increase after the ketogenic and low-carbohydrate phases (K1 and LC1; at 
t2) but after 1 year there was overall no significant difference compared to starting (t6 vs. t0), the increase seen 
was short term. LDL-C also decreased at t2 and in contrast to HDL the decrease remained significant throughout 
the study (p < 0.0001 t2 vs. t0; p = 0.004 t6 vs. t0). TG declined significantly at t2 compared to t0 (p = 0.0006) 
and for t6 vs. t0 (p = 0.01) although there was no significant difference between t2 and t6. Finally blood glucose 
decreased significantly at t2 vs. t0 (p < 0.0001) after which it rose but at the end of the 12 months it was still 
significantly lower at t6 vs. t0 (p = 0.0004). No significant changes were observed in ALT, AST, GGT, 
Creatinine or BUN. 
 
Table 1.3. Changes in blood biochemical and pressure parameters at baseline (t0), after first period of ketogenic diet and low 
carbohydrate diet (t2) and after one year from the start (t6). Values are expressed as mean and standard deviation. 
 
Blood Parameters t0 t2 t6 t0 vs t2 t0 vs t6 t2 vs t6 
Chol-tot 193.2±37.87 171.9±31.94 179.8±32.42 p < 0.0001 p = 0.0003 n.s. 
HDL-c 43.03±6.09 49.59±8 44.59±8 p < 0.0001 n.s. p < 0.001 
LDL-c 144.5±58.4 108.0±42.66 122.9±42.25 p < 0.0001 p = 0.0004 p < 0.0001 
TG 112.7±61.02 88.62±40.65 95.45±39.99 p = 0.0006 p = 0.0106 n.s. 
Glu 102.6±11.5 90.31±8.45 95.31±8.45 p < 0.0001 p = 0.0004 p < 0.0001 
ALT 18.75±11.6 16.53±6.72 17.11±9.3 n.s. n.s. n.s. 
AST 18±8.69 17.13±7.2 17.76±5.43 n.s. n.s. n.s. 
GGT 20.68±16.16 16.1±5.3 17.8±6.8 p = 0.012 p < 0.05 n.s. 
Creatinine 0.79±0.16 0.76±0.07 0.77±0.1 n.s. n.s. n.s. 
BUN  15.87±3.83 16.1±85.29 15±3.87 n.s. n.s. n.s. 
Uric acid 4.56±0.86 4.2±0.64 4.01±0.91 p < 0.01 p < 0.05 n.s. 
SBP 125 ± 10 117±6 118±4 p < 0.01 p < 0.01 n.s. 
DBP 86±5 82±8 82±5 n.s. n.s. n.s. 
 
n.s. = not significant. 
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Discussion 
There is no universally accepted definition of “successful weight loss maintenance” following a diet, but a 
reasonable candidate would be that proposed by Wing and Hill in 2001, which defines it as “individuals who 
have intentionally lost at least 10% of their body weight and kept off at least one year” (Wing, Hill 2001). The 
criterion of 10% is chosen for its well-documented effects in the improvements in risk factors for diabetes and 
cardiovascular disease, while the one year duration criterion was proposed in agreement with the USA Institute 
of Medicine (Thomas 1995). The data from our present study suggest that two brief periods of a 
“Mediterranean” variant on the VLCKD theme (which we call KEMEPHY) are able to induce significant weight 
and body fat loss that was maintained for at least one year. In particular, the weight loss reached at six months, 
after the second cycle of VLCKD, was maintained, without weight regain, over the subsequent six months of 
normocaloric Mediterranean nutrition.  
The Mediterranean diet is associated with a longer life span (Trichopoulou, Kouris-Blazos et al. 1995), lower 
rates of coronary heart disease (Chahoud, Aude et al. 2004), hypercholesterolemia (Perona, Cabello-Moruno et 
al. 2006), hypertension, diabetes and obesity (Richard, Couture et al. 2013). However, it is difficult to isolate the 
“healthy” constituents of the Mediterranean diet, since it is not a single entity and varies between regions and 
countries. Since there is no “one size fits all” dietary recommendation, we have tried to merge the benefits of 
these two approaches: the long term “all-life” Mediterranean diet coupled with brief periods of a metabolism 
enhancing ketogenic diet. 
Data from this study report that the majority of subjects maintained > 10% weight loss at 12 months, while 8 
subjects didn’t (Figure 1.3). These 8 subjects were included in the final statistical calculations, but the post 
dietary analysis showed that they were not compliant with the nutritional guidelines given for the Mediterranean 
diet period and they returned to their previous nutritional habits (“junk” food, high glycaemic index. etc). This is 
not in agreement with previous data, which show that low carb diets show lower compliance in the long term 
compared to low fat diets (Greenberg, Stampfer et al. 2009).  
 
Figure 1.3. Changes in weight (% of change) of each subject (t6 compared to t0). Basal value is represented by the line zero. 
Each circle represents a single subject. 
 
Many others factors beyond the return to previous nutritional habits can be involved in weight regain. These 
includes resting metabolic rate (RMR), insulin & leptin resistance and changes in the levels of several hormones 
involved in the homeostatic regulation of body weight (Sumithran, Prendergast et al. 2011). RMR could be 
affected by the loss of muscle mass due to an inadequate protein intake during dieting. The suggested daily 
protein consumption is around 15% in a classical hypocaloric Western diet of about 1200 Kcal/day so the actual 
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protein content will be approximately 45 g (180 Kcal; 4 Kcal/g). Hypothesizing a body weight of 70 kg this daily 
protein intake will be 0.64 g per kilogram of body weight, which is a possible cause of muscle loss and 
consequent reduction of resting energy expenditure. The VLCKD on the other hand appears not to influence 
(either positively or negatively) the basal energy expenditure (Paoli, Grimaldi et al. 2012). Regarding hormonal 
influences on weight regain a possible explanation involves a long-term increase in orexigenic signals. 
Sumithran and co-workers showed that a very low calorie diet causes a persistent elevation of the circulating 
mediators of appetite that encourages weight regain even one year after initial weight reduction (Sumithran, 
Prendergast et al. 2011). On the other hand it has been demonstrated that a ketogenic diet has only a minor effect 
on ghrelin levels and that the subjective ratings of appetite were lower when participants were in a state of 
physiological ketosis (Sumithran, Prendergast et al. 2013). 
 
Conclusions 
In summary the data from this study demonstrate that the majority of subjects showed significant weight loss 
(10%) as a result of a two-phase VLCKD and were compliant both during the six month weight loss phase and 
the six month normocaloric maintenance phase, with no weight regain. We can suggest that the proposed 
protocol was generally successful because of (a) the protein mass protective effects of a VLCKD and (b) the 
prescription of a traditional Mediterranean diet in the post weight-loss phase was especially important for 
achieving “weight loss success”, i.e., continued weight loss for at least one year. 
 
Table 1.4. Herbal extracts used during KEMEPHY diet. 
 
Plant extracts VLCKD LCD Composition 
Extracts A, ml/day 20 20 Durvillea Antartica, Black Radish, Mint, Liquorice, Horsetail, Burdock 
Dandelion, Rhubarb, Gentian, Lemon Balm, Chinaroot, Juniper, Spear 
Grass, Elder, Focus, Anise, Parsley, Bearberry, Horehound 
Extracts B, ml/day 20 20 Serenoa, Red clover, Chervil, Bean, Elder, Dandelion, Uncaria, Equisetum, 
Horehound, Rosemary 
Extracts C, ml/day 50 50 Horsetail, Asparagus, Birch, Cypruss, Couch Grass, Corn, Dandelion, 
Grape, Fennel, Elder, Rosehip, Anise 
Extracts D, ml/day 40 0 Eleuthero, eurycoma longifolia, ginseng, corn, miura puama, grape, 
guaranà, Arabic coffee, ginger 
 
Table 1.5 Main actives ingredients of used phytoextracts, their reported effects and related references. 
 
Extract Main Active Ingredients   Reported beneficial effects Refs 
A Mint, black radish, burdock Indigestion 
Antioxidant 
Choleretic, increases bile secretion 
helping digestion 
(Lugasi, Blazovics et al. 2005, 
Lou, Wang et al. 2010) 
 
B Serenoa Repens (saw palmetto) Hormonal regulating effects (Di Silverio, D’Eramo et al. 1992) 
White bean Alpha-amylase inhibitory properties and 
has been reported to aid weight loss and 
glycaemic control 
(Barrett, Udani 2011, Celleno, 
Tolaini et al. 2007) 
C Equisetum Antioxidant 
Diuretic 
Glycaemic control 
(Mimica-Dukic, Simin et al. 2008, 
Safiyeh, Fathallah FB, et al. 2007) 
Dandelion (Taraxacum 
officinale) 
Diuretic 
 
(Clare, Conroy et al. 2009) 
D Ginseng, Miura Puama, 
Guaranà 
Ameliorate the commonly reported 
symptoms of weakness and tiredness 
during the initial VLCKD phase 
(Pieralisi, Ripari et al. 1991, Piato, 
Detanico et al. 2010, Lima, 
Carnevali et al. 2005) 
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2. THE EFFECTS OF DIFFERENT HIGH-PROTEIN LOW-CARBOHYDRATES 
PROPRIETARY FOODS ON BLOOD SUGAR IN HEALTHY SUBJECTS 
Lodi A, Karsten B, Bosco G, Gómez-López M, Brandão PP, Bianco A, Paoli A, The Effects of Different High-Protein Low-
Carbohydrates Proprietary Foods on Blood Sugar in Healthy Subjects. J Med Food, 2016. 
 
 
Introduction 
Although it is recognized that the VLCKDs lead to greater weight losses than a low-calorie balanced diet at least 
in the short term (Bueno, de Melo et al. 2013), subjects with a sweet food preference may not adhere to this diet 
because of the lack of their preferred taste (Shai, Schwarzfuchs et al. 2008b, McVay, Voils et al. 2014). 
The tendency to prefer sugary fatty foods over savory foods is considered innate and universal and finds its roots 
in very important adaptive processes: a bitter taste is considered predictive of toxicity and then avoided 
(alkaloids, glycosides, and other toxins have a bitter taste), whereas sweet taste is associated with energy and 
nourishment (Drewnowski, Krahn et al. 1992).   
Populations experiencing an increase in obesity and CV diseases show common eating and drinking habits, 
notably a general decrease in intake of minimally processed foods and in an increase in the consumption of 
ultraprocessed ready-to-consume products. These foods, based on the accepted definition acknowledged by the 
Pan American Health Organization (PAHO WHO 2015) are ‘‘industrial formulations manufactured from 
substances derived from foods or synthesized from other organic sources. (...) Most of these products contain 
little or no whole food. They are ready-to-consume or ready-to heat, and thus require little or no culinary 
preparation.’’ Examples of ultraprocessed foods are savory and sweet snacks, ice cream, frozen and chilled ready 
meals, and soft drinks (PAHO WHO 2015) and they seem to be the cause of the extra daily diet calorie intake of 
both the young and the older populations (Monteiro, Moubarac et al. 2013). Ultraprocessed ready-to-consume 
products present particular characteristics, which make them extremely profitable for producers and retailers and 
highly attractive for consumers. For example, consumers purchase them because they commonly require a 
minimal culinary action, they are flavorsome, and are relatively inexpensive.  
However, when analyzing ultraprocessed products, less protein, potassium, and dietary fiber and more free 
sugar, total saturated and transunsaturated fats, and sodium are generally evident when compared with traditional 
foods (Monteiro, Levy et al. 2011, Moubarac, Batal et al. 2014). All these characteristics appear to be linked to 
the burden of obesity and metabolic syndrome (MetS) (Monteiro, Moubarac et al. 2013).  
A potential solution to this scenario could be to review ultraprocessed, ready-to-consume products by reduction 
of their sugar and fat contents. A particular kind of these new ultraprocessed ready-to-consume products are 
proprietary foods that are high in proteins and fibers and low in sugar and saturated fats. These are specifically 
designed for particular diets such as the ketogenic regimen, but are also successfully used in more easy low-
carbohydrate (CHO) diets as snacks or meal replacements (Paoli, Cenci et al. 2011). During ketosis, CHO intake 
must be under 30g/day (Paoli 2014, Paoli, Rubini et al. 2013d) and in previous studies (Paoli, Bianco et al. 2013, 
Paoli, Cenci et al. 2011) we demonstrated that these special foods, which mimic the taste and aspect of high-
content CHO foods but are low in sugar and high in protein content, were able to increase the compliance of 
subjects to the ketogenic diet. Moreover, after the termination of a very low-CHO ketogenic diet (VLCKD) 
intervention, patients tended to maintain the consumption of those proprietary foods during the day (usually at 
breakfast or during breaks). This can be considered a positive change of behavior, because it is known that meal 
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replacement during the maintenance phase is useful to prevent weight gain (Vázquez, Montagna et al. 2009). 
During consumption of a VLCKD, it is mandatory to maintain a low level of glycaemia (about 80–90 mg/dL) to 
avoid insulin spikes (Paoli, Canato et al. 2011). This condition allows subjects to improve their fat oxidation as 
demonstrated by Paoli et al.  (Paoli, Grimaldi et al. 2012)  and by Tagliabue et al. (Tagliabue, Bertoli et al. 
2012). 
Another important aspect of a VLCKD is the influence of such dietary regimen on the perception of hunger 
(Gibson, Seimon et al. 2015). It has been suggested that ketone bodies reduce hunger through different and 
complex mechanisms (Paoli, Bosco et al. 2015); in contrast it is known that postprandial glucose and insulin 
spikes, typically produced after the intake of traditional ultraprocessed products that usually show a high 
glycaemic index (GI) (PAHO WHO 2015), elicit food craving and overeating, with a preference for high-GI 
CHOs(Lennerz, Alsop et al. 2013) a phenomenon defined as the CHO-craving effect (Ventura, Santander et al. 
2014). Conversely, the consumption of nonprocessed foods low in simple sugars may ameliorate overeating and 
facilitate the maintenance of a healthy weight (Lennerz, Alsop et al. 2013). 
The mentioned positive changes necessitate the need to analyze the effect of different high-protein low-CHO 
proprietary foods that are commonly used in diets, i.e. during VLCKD and low-CHO diets (LCD), on glycaemia 
compared with glucose. 
 
Materials and Methods 
Subjects were recruited through advertisement placed in two pharmacies located in the province of Vicenza. 
Exclusion criteria for this study were the presence of diabetes or prediabetes, being on a food diet, and females 
who were either pregnant or breast-feeding. After a preselection process of 32 participants, 14 females were 
eligible to participate in this study (mean age: 42 – 13, mean weight: 72 – 21 kg, mean BMI: 26 – 7). Participants 
were required to report any change of daily habits, such as engaging in a new exercise program, new 
pharmaceutical interventions, or engaging in other than the present diets during the experimental phase, which 
would have resulted in the exclusion from the study. The study was approved by the Ethical Board of the 
University of Padova, Department of Biomedical Sciences, and conformed to standards for the use of human 
subjects in research as outlined in the Declaration of Helsinki. Investigators explained the purpose of the study, 
the protocol to be followed, and the experimental procedures to be used before the start of the study. Subjects 
were required to sign a participation consent form and they did not receive any monetary compensation. 
Subjects were tested for individual glycaemic response curves elicited by the ingestion of 1000 kJ of glucose 
three times within a 3-week period (one test per week) and that of each of 10 high-protein low-CHO proprietary 
test foods once on separate days twice a week (Fig. 2.1). Tests were performed in the morning after 10–12 h 
overnight fast. Subjects were asked to have a regular meal, not to consume any alcohol, and to avoid any 
unaccustomed exercise the night before tests. During the study period, participants maintained a constant foods 
supply, without changing their usual eating habits. 
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Figure 2.1. Experimental design 
 
Fingertip capillary blood samples were collected in the fasted state and after 15, 30, 45, 60, 90, and 120 min after 
starting to eat, changing the finger each time to avoid traumatization of the skin. The puncture was performed 
with the lancet Accu-Check Safe-T-Pro Plus (Roche Diagnostics, Basel, Switzerland) and blood was collected 
directly and immediately analysed using test strip Reflotron® Glucose(Bijster 1993, Richter, Rassoul et al. 2007, 
Warnick, Boerma et al. 1993). Postprandial effect of sugar content on glycaemia is commonly defined through 
three methods: the GI, the glycaemic load (GL), and the glycaemic score (GS). 
The GI method was developed to rank foods according to the extent to which they increase blood sugar 
concentrations (Holt, Miller et al. 1997) and it is a number that ranges from 0 to 100, where 100 represents the 
GI of the reference food glucose. To calculate the GI of a particular food, the area under the curve (AUC) of the 
rise in blood sugar for a 2 h postprandial period is calculated. This value is consequently expressed as a 
percentage of the incremental AUC after the consumption of a reference food (commonly white bread or 
glucose) consumed by the same person on a different day (FAO 1998). The test food and the reference food must 
contain the same amount of available CHO (25 or 50g) and the individual has to perform the test under 
standardized conditions. 
 
 
 
The GL method takes into account not only the magnitude of the glucose blood spike but also the content 
(grams) of CHO in the portion of food consumed, and it is calculated as the mathematical product of the GI for 
the available CHO content of the food (Bao, Atkinson et al. 2011). 
 
 
 
The GS method tests the glycaemic response after the ingestion of low-CHO foods and differs from the GI as it 
does not compare a standard amount of available CHO. However, it compares the effect on glycaemia of a 1000 
kJ portion of both test food and reference food (Bao, Atkinson et al. 2011). 
 
 
WEEK n.1 
•Reference 
Food  
First Test 
WEEK n.2 
•Reference 
Food 
 Second 
Test 
WEEK n. 3 
•Reference 
Food  
Third Test 
WEEK n. 4 
• Test Food 
CB and 
Test Food 
PD on 
separate 
days. 
WEEK n. 5 
•Test Food 
CAPB and 
Test Food 
NCM on 
separate 
days. 
WEEK n. 6 
• Test Food 
CD and 
Test Food 
CHB on 
separate 
days. 
WEEK n. 7 
•Test Food 
RB and 
Test Food 
ACB on 
separate 
days. 
WEEK n. 8 
• Test Food 
P1 and 
Test Food 
P2 on 
separate 
days. 
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Due to the very low-CHO content of the tested foods and because of the quantity of food required to reach the 25 
g of available CHO for the calculation of GI being too large, this study utilized the GS method (Bao, Atkinson et 
al. 2011). 
Each tested food was served as a 1000 kJ portion with 220 mL warm (no sugar) tea for a better compliance of 
subjects in cold winter mornings after an overnight fast (tea does not alter the incremental area under the 
glycaemic response curve (Brouns, Brouns et al. 2005)) and consumed within a period of 10 min. This study 
tested 10 proprietary foods selected from the product range of Tisanoreica® snacks and meals (Gianluca Mech 
S.p.A., Asigliano Veneto, Vicenza, Italy). These are ready-to-consume foods high in protein and fiber content 
and low in CHO content designed to be consumed during a VLCKD or an LCD regimen (Paoli, Bianco et al. 
2013, Paoli, Cenci et al. 2011, Paoli, Grimaldi et al. 2012b). 
Among the products selected, six of them were sweet (chocolate biscuits [CB; Cioco-Mech], chocolate and ha- 
zelnut balls [CHB; Bon Mech], apple–cinnamon biscuits [ACB; T-Biscuit], chocolate–almonds–pistachio bar 
[CAPB; T-Smart], nuts and chocolate muffin [NCM; T-Muffin], and chocolate drink [CD; Cocoa Drink]). The 
other four products tested were savory (two different types of pasta P1 [Original Tisanopast] and P2 [Tisanopast 
Style], the rosemary bread- sticks [RB; T-Smech], and the pizza dough [PD; Pizza Dough]) (Table 2.1). Glucose 
was used as reference food. This was dissolved in 220 mL of water and served as 1000 kJ portions (15.68kJ/g)  
(Plowman, Smith 2013) and had to be consumed within a 10 min period. 
 
Table  2.1. Test Foods Characteristics 
 
 
 
All statistical analyses were performed using package GraphPad Prism version 6.00 for Mac, GraphPad Software 
(San Diego, CA, USA). The AUC values above the fasting glucose concentration for each test food and for the 
reference food were used to calculate the GS of each test food and assessed using an XY data table by selecting 
the AUC analysis. The effect of each test food on glycaemia compared with that of the reference food over time 
was assessed using a mixed model ANOVA (time · treatment). A post hoc Sidak’s multiple comparison test was 
performed. 
To select those test foods with a significant difference of blood sugar values compared with the other test foods, 
a two-way repeated measure ANOVA (time vs. nominal variables test foods vs. measures) was performed. Each 
row represented a different time point, so matched values were stocked into a subcolumn. Tukey’s multiple 
comparison test was chosen to compare columns within each row. 
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A bivariate analysis was used to test, through a linear regression analysis, the significance of the associations be- 
tween GS and sugars, and protein and fiber in the 10 foods tested. An alpha level of P < 0.05 was used to denote 
a significant effect. 
 
Results 
Mean GS, mean glycaemia, and mean glycaemia in the different time points of the 10 test foods and the 
reference food among the subjects tested are listed in Table 2.2. Mean glycaemia after taking the reference food 
glucose resulted in 122 ± 15 mg/dL, that after taking the sweet test foods was 89 ± 7 mg/dL, and that after 
ingestion of the savory test foods was 91 ± 8 mg/dL. 
Figure 2.2 shows the comparison of mean blood sugar concentrations at the different time points between 
glucose and sweet test foods, whereas Figure 2.3 shows that between glucose and savory test foods. After the 
ingestion of all sweet and savory test foods, the blood sugar showed always a significantly lower trend compared 
with that after the intake of the reference food glucose after 15, 30, 45, 60, and 90 min, although several test 
foods (CHB, CAPB, NCM, ACB, PD, and RB) were able to maintain this significance even after 120 min. 
Figure 2.4 shows the comparison of blood sugar concentrations between sweet test foods and savory test foods. 
Comparison of mean blood sugar concentrations at the seven different time points highlighted a significant 
higher increase of glycaemia, particularly 15 and 30 min after taking the CHB and the two kinds of pasta P1 and 
P2 compared with the other test foods (Fig. 2.4). 
In particular, the mean glycaemia increased significantly 15 and 30 min after the intake of CHB compared with 
the mean glycaemia after the ingestion of the CB, the CAPB, the RB, and the PD (Fig. 2.5). 
After the intake of P2, the mean glycaemia increased significantly after 15 and 30 min. compared with the sweet 
test foods CB, CAPB, and NCM and with the savory test foods PD and SB (Fig. 2.6). 
After the intake of P1, the mean glycaemia increased significantly after 15 and 30 min. compared with the sweet 
test foods CB and CAPB and with the savory test foods PD and RB (Fig. 2.7).  
The statistical two-way ANOVA of the trend of blood sugar from before starting to eat up to 2 h after the intake 
of the reference food or of the test foods shows that, on average, the 40% of the total variation observed is 
because of the difference between the foods eaten (glucose or test foods). This result shows that, among all the 
‘‘Sources of Variation’’ analysed (time, food, and subjects), the variable ‘‘food’’ appears to be the one that 
explains most of the variation observed between the blood sugar trends after the intake of test foods and the 
blood sugar trend after the intake of the reference food. The results did not show any correlation between GS and 
fiber content (r = -0.08; P = 0.37), neither between GS and sugar content (r = 0.17; P = 0.09), nor between GS 
and protein content (Fig. 2.8). 
The average GS of each test food, calculated as the mean of GS values of each test food resulted from every 
subject, was always less than 25 compared with the GS reference value of glucose, which is 100 (Table 2.2). The 
test food with the highest GS is the sweet test food Bon Mech with a GS of 23. The test food with the lowest GS 
is the sweet test food Cioco Mech and T-Smart, with a GS of 14. 
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Figure 2.2.  Comparison of mean blood sugar concentrations between glucose and sweet test foods (*P <0.05; **P < 0.01; 
***P < 0.001; ****P < 0.0001). Foods were tested among 14 healthy subjects. All tested foods and the reference food 
glucose were served as a 1000 kJ portion and consumed within 10 min. 
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Figure 2.3. Comparison of blood sugar concentrations between glucose and savory test foods (*P<0.05; **P<0.01; 
****P<0.0001). Foods were tested among 14 healthy subjects. All tested foods and the reference food glucose were served as 
a 1000 kJ portion and consumed within 10 min. 
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Figure 2.4 Comparison of blood sugar concentrations between sweet test foods and savory test foods. Among sweet test 
foods, the CHB show a higher increase in blood sugar than other test foods (significant differences are shown in Fig. 5). 
Among savory test foods, both pasta type 2 (P2) and pasta type 1 (P1) show a higher blood sugar trend (significant 
differences are shown in Figs. 6 and 7). CHB, chocolate and hazelnut balls. 
 
 
 
 
 
 
 
 
 
Figure 2.5. Comparison of mean blood sugar concentrations between the CHB and the other test foods. Results show 
significant differences after 15 or 30 min between CHB and CB, RB, PD, and CAPB. *P <0 .05; **P < 0.01; ***P < 0.001. 
CAPB, chocolate– almonds–pistachio bar; CB, chocolate biscuits; PD, pizza dough; RB, rosemary breadsticks. 
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Figure 2.6. Comparison of mean blood sugar concentrations between pasta type 2 (P2) and the other test foods. Results show 
significant differences after 15 or 30min between P2 and CB, CAPB, PD, NCM, and RB. *P < 0.05; **P < 0.01;             
****P < 0.0001. NCM, nuts and chocolate muffin. 
 
 
Figure 2.7. Comparison of mean blood sugar concentrations between the pasta type 1 (P1) and the other test foods. Results 
show significant differences after 15 or 30min be- tween P1 and CB, CAPB, PD, and RB. *P < 0.05; **P < 0.01;              
***P < 0.001; ****P < 0.0001. 
 
 
Figure 2.8. Bivariate correlations between observed glucose responses (GS) (relative to 1000 kJ glucose = 100), the available 
sugars, protein, and fiber contents of the 10 single test foods. Linear regression analysis was used to test the significance of 
the associations. Each point on the graph represents the mean result for each test meal (14 subjects). (A) Sugars—GS linear 
regression; (B) protein—GS linear regression; (C) fiber—GS linear regression. GS, glycaemic score. 
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Discussion 
In this study, the GS of 10 proprietary foods high in proteins and fibers and low in sugars and saturated fats was 
tested. These proprietary foods claim to replicate the taste and aspect of high-CHO foods and are projected to be 
used as meals during VLCKD regimens. In our study, the products tested showed a significant lower blood sugar 
response and lower GS than an isoenergetic amount of glucose. Among he six sweet and four savory test foods, 
the CHB showed the highest GS (GS = 23). This result is consistent with the higher quantity of available sugars 
of CHB compared with the other test foods. The CB and the CAPB had the lowest GS of 14. This GS value is, 
according to the data available (Bao, Atkinson et al. 2011), similar to the GS value of a low-fat processed cheese. 
The macronutrient composition is important for glucose response, with CHO as the food component that acts 
directly on glycaemia, raising it and stimulating insulin secretion. However, even if CHO counting is still the 
basis for insulin dose adjustment in diabetes care management (Campbell, Walker et al. 2016), data show (Bao, 
Atkinson et al. 2011) that sugar content could be a stronger predictor of the observed glucose response than 
CHO. Other studies show that the structure of CHOs should also be kept under consideration: a disrupted 
structure, typical of processed whole grains, has a different effect on glycaemia compared with intact grains 
(Foster-Powell, Holt et al. 2002). 
Even if there is a strong evidence supporting fibers’ beneficial effect in reducing disease risk (Bao, Atkinson et 
al. 2011), only soluble fibers with gel-forming properties show a distinguishable effect for glycaemic control 
(Venn, Mann 2004, Gibb, McRorie et al. 2015). 
This study does not show any significant relationship between GS and fiber content, but, differently from them, 
it does not show any correlations between GS and sugar content (Fig. 2.8). This conflicting result might be 
because of the very low quantity of available sugars in the test foods. Finally, protein content, despite being 
considered predictive for the GS (Bao, Atkinson et al. 2011), did not show such correlation in this study. 
The low postprandial glycaemia produced by the proprietary foods tested is an important factor, because ultra- 
processed ready-to-consume products are commonly high in simple sugars that negatively affect a number of 
health parameters. Postprandial hyperglycaemia and compensatory hypoglycaemia are factors linked to the 
development of diabetes and CV diseases (Zeevi, Korem et al. 2015). Furthermore, the consumption of high-
sugar snacks seems to be the main cause for the increase in intrahepatic triglyceride content (Koopman, Caan et 
al. 2014). Finally, the usual rapid and high glycaemic peak caused by ultra-processed products, together with 
their lack in fiber, proteins, and water, triggers an excessive consumption (Ventura, Santander et al. 2014, Blum, 
Thanos et al. 2014). Sugar is rapidly absorbed and produces a consequent high blood sugar spike that acts 
centrally, increasing the production and utilization of dopamine, which imitates the typical neuromodulation of 
addictive substances (Blum, Braverman et al. 2000). The abuse of high sugary ultraprocessed foods leads to the 
synthesis and the accumulation of fat and results in weight gain (Moubarac, Batal et al. 2014) which increases 
the risk of obesity and MetS. Bielemann et al. (Bielemann, Motta et al. 2015)  recently demonstrated that 
ultraprocessed foods were responsible for 50% of the daily caloric intake among a cohort of 23-year-old 
participants in Brazil. Interestingly, the household availability of ultraprocessed ready-to-eat foods was 
associated with a low percentage of proteins and fibers intake. 
Appetite control is related not only to glucose content and postprandial glycaemia but also to other factors (Farr, 
Chiang-shan et al. 2016) among which the reward system in the brain, aside from the homeostatic control by the 
hypothalamus, has been the focus of recent interest, since food reward is a goal that drives both appetite and 
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eating (Rolls 2016, Rogers, Brunstrom 2016). The larger the portion size, the more food is eaten, but eating is 
only indirectly related to energy balancing because it seems that we eat essentially for pleasure (Rogers, 
Brunstrom 2016). These new low-calorie proprietary foods could help to reduce energy intake, useful for a better 
weight maintenance or a more successful weight loss. Moreover, since high-energy-dense foods have the lowest 
satiating capacity even if they usually have a high palatability (Rogers, Brunstrom 2016), the high level of 
proteins and fibers and the high palatability, despite the low sugar content of these new ultraprocessed foods, are 
important features that contribute to both food reward and satiety (Tovar, del Carmen Caamaño et al. 2012). 
A VLCKD that includes these proprietary foods that imitate taste and aspects of high-CHO food but have a low 
glucose content can consequently produce a higher level of adherence and a reduced drop-out rate (Mutch, 
Clement 2006, Paoli, Cenci et al. 2010). 
Sweet foods are usually rich in refined CHO, have a high GI, and are related to an increased risk of overweight, 
obesity (Schwingshackl, Hoffmann 2013), and type 2 diabetes mellitus (T2DM) (Maki, Phillips 2015) . T2DM is 
increasing among young people (Reinehr 2013) and a dietary management is the most important factor to be 
considered to prevent the progression of impaired glucose tolerance to clinical DM. A dietary management is 
also important to minimize the glycaemic variability, which is the measure of blood sugar concentration changes 
over time (Tay, Thompson et al. 2015). An uncontrolled blood sugar concentration is the major risk factor in the 
development of T2DM complications such as retinopathy, neuropathy, nephropathy, and CV diseases 
(Brownlee, Hirsch 2006, Forbes, Cooper 2013, Bonora 2002, Pradeepa, Mohan 2011). It is important to make 
healthier nutritional choices to prevent these complications, which are associated with high economic, social, and 
personal costs. Low-CHO high-protein diets help to normalize glycaemic fluctuations in T2DM management 
(Feinman, Pogozelski et al. 2015). As suggested by the European Association for the Study of Diabetes (EASD), 
dietary fibers can further positively influence blood sugar variability. The EASD consequently recommends the 
consumption of high-fiber, low-GI foods as CHO source (Tay, Thompson et al. 2015). 
Dietary amino acids contribute to the de novo synthesis of glucose through gluconeogenesis and participate in 
the recycling of glucose carbon through the glucose–alanine cycle (Dashty 2013). However, dietary proteins 
have a minimal impact on glycaemia and insulin secretion compared with CHOs (Layman, Baum 2004), and a 
high-quality protein supplementation has been suggested during weight loss programs to preserve muscle mass, 
to improve glycaemic regulation, and to maintain euglycaemia (Verreijen, Verlaan et al. 2015, Pasiakos 2015). 
The 10 proprietary foods tested in this study are formulated with whey proteins. These, because of their high 
content of leucine, which promotes muscle mass synthesis and because of their fast digestion and delivery of 
amino acids in the circulation, are consequently considered the best type of proteins (Verreijen, Verlaan et al. 
2015). Moreover, whey protein decreases appetite better than other types of proteins (Pal, Ellis 2010) and 
increases satiety through an increase of the release of CCK and GLP-1 and a reduction of ghrelin levels 
(Luhovyy, Akhavan et al. 2007). 
The sweet proprietary foods tested in this study also contained low-calorie sweeteners. These are compounds 
able to stimulate, in the same way as sugar does, the sweet taste receptors (Brown, Rother 2012). Unlike sugar, 
low-calorie sweeteners do not release energy and hence they are used in weight loss programs even though 
perceived as controversial by the scientific community. This is due to low-calorie sweeteners producing possible 
adverse metabolic effects, such as increase of appetite, weight gain, and metabolic disorders (Yang 2010, 
Swithers, Martin et al. 2010, Ludwig 2009). However, more studies are required to confirm these negative 
suggestions, since a recent review shows that there is no evidence for a limitation of their use to reduce energy 
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intake (Rogers, Hogenkamp et al. 2015). The same author states that our congenitally liking for sweetness 
implies that the reward value from sugar and low-calorie sweeteners is the same, but low-calorie sweeteners 
should be preferred, because they avoid the high-calorie intake side effect of sugar (Rogers, Brunstrom 2016). 
These compounds could be useful in the prevention of overweightness and obesity in populations that are less 
sensitive to sweetness, predisposing them to consume more sugar to have the same ‘‘taste sensation’’ as people 
more sensitive to sweetness (Low, Lacy et al. 2014). Nowadays low-calorie sweeteners are important tools in 
DM management, in which dietary adherence is among the most difficult cornerstones (Anders, Schroeter 2015), 
especially for children and adolescents with T2DM who suffer from the perceived lack of normality in their diet 
and consequently desire non-recommended sweet foods (Mulvaney, Schlundt et al. 2006). 
 
Conclusions 
The 10 proprietary foods tested showed a significant lower glycaemia than the standard food glucose and their 
GS resulted in always lower than 25. This low glycaemic response, together with their valuable ready-to-use 
format, makes these proprietary foods a valid tool during both weight management and weight loss programs, 
improving the adherence to KDs of individuals who tend to have a high preference for sweet foods. Moreover, 
these new ultraprocessed products high in protein and fibers and low in sugars could ameliorate both the diet of 
young people and the diet of T2DM patients. In the former population, this could prevent them from eating high-
sugary fatty foods, predisposing them to the development of T2DM, and in the latter to minimize blood sugar 
variability that often complicates the pathology.  
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3. WEIGHT LOSS AND COGNITIVE FUNCTIONS: THE EFFECTS OF 
GLYCAEMIA AND KETONEMIA VARIATION IN NON DIABETIC 
OVERWEIGHT YOUNG WOMEN 
 
INTRODUCTION 
The range of variation of both glucose and ketone bodies in the blood of non-diabetic individuals is wide. 
Glycaemia ranges from fasting concentration between 3.9 and 5.5 mmol/L (70 to 100 mg/dl)	 (Brent	Wisse	2015)	to higher values after eating, which rarely exceed 7.78 mmol/L (140 mg/dl) (Singh	2012). Ketone bodies 
(KBs) level ranges from 0.1 mmol/L during a standard carbohydrate-fed diet to 7/8 mmol/L during a ketogenic 
diet 	(Paoli,	Canato	et	al.	2011)	. 
Both glucose and KBs are used as energy from the brain and have different effects on cognitive functions 
depending on their blood concentration.  
Regarding blood glucose, acute hyperglycaemia typical of diabetic individuals is related with mild cognitive 
dysfunctions, producing a slowdown of all cognitive performance tests (Cox,	Kovatchev	et	al.	2005); the same 
results were obtained testing hypoglycaemia 	(Graveling,	Deary	et	al.	2013,	Languren,	Montiel	et	al.	2013)	 . 
However, recurrent hypoglycaemia was related with improved cognitive functions in both diabetic and healthy 
animals tested at euglycaemia (McNay,	 Sherwin	 2004). In non-diabetic humans, a study reported that 
individuals with poorer glucose tolerance had faster working memory and lower depression compared to subjects 
with better glucose tolerance (Young,	Benton	2014). 
Considering KBs, their	 uptake	 in	 the	 brain	 is	 largely	 irreversible	 and	 doesn’t	 saturate	 at	 physiological	ranges	 of	 ketonemia,	 contrary	 to	 glucose	 which	 tend	 to	 decrease	 when	 glycaemia	 elevates	 (Bouteldja,	Andersen	et	al.	2014). When	 beta-hydroxybutyrate	 (βOHB)	 level	 is	 low	 (<0.5	mmol/L)	 it	 contributes	 to	 no	more	 than	 3%	 of	brain	 energy	 requirements	 (Courchesne-Loyer,	 Croteau	 et	 al.	 2016),	whilst	 at	 level	 of	 4.8	mmol/L	 KBs	(AcAc	plus	 	βOHB	)	supply	the	33%	of	total	brain	energy	requirements(Courchesne-Loyer,	Croteau	et	al.	2016).	 Studies comparing ketogenic diets with high carbohydrate diet reported either a similar effect on 
cognitive functions of both diets (Makris,	 Darcey	 et	 al.	 2013) or an impairment during the ketogenic diet (Holloway,	Cochlin	et	al.	2011,	Edwards,	Murray	et	al.	2011). 	
As there is no data of the effects of glycaemia and ketonemia variations on cognitive functions following 
different diets in overweight non-diabetic young women, the	purpose	of	this	study	was	then	to	compare	the	glycaemia	and	ketonemia	before	and	after	 ten	days	of	very	 low-carbohydrate	ketogenic	diet	without any 
restriction of calories intake (KD)	with	a	calorie-restricted	ketogenic-mediterranean	diet	(KEMEPHY)	and	a	calorie-restricted	Mediterranean	 diet	 (MD)	 on	working	memory	 and	 executive	 functions	 in	 overweight	young	women.		
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SUBJECTS AND METHODS  
 
Subjects 
 
Subjects were recruited through leafleting in the university area.  
Inclusion criteria for the diet-group were: overweight or obese young women, age between 20 and 35 years, 
25<BMI>39.9 kg/m2 (Clinical guidelines on the identification, evaluation, and treatment of overweight and 
obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of 
Overweight in Adults. 1998) 
Inclusion criteria for the non-diet group were: normal weight young women (18.5<BMI<25 kg/m2 ), age between 
20 and 35 years. 
Exclusion criteria for both groups were: smokers, subjects under diet-treatment, subjects treated for diseases 
such as diabetes, cardiovascular diseases, depression, subjects doing sport more than 2 hours per week (Edwards, 
Murray et al. 2011)). 
For the diet-group were recruited a total of 63 sedentary overweight and obese girls and 45 of them completed 
the study.  
For the normal-weight group a total of 17 girls were recruited (21±1.8 kg) and 17 completed the study. 
 
Study design 
 
The study was driven from April 2015 to June 2016. 
Subjects were contacted per mail and divided in groups according to the day of the beginning of their follicular 
phase in order to minimize hormonal effects on mood (Aitken, Baker et al. 2008). 
Each group of subjects came for the basal measurements after an overnight fast to the Exercise Laboratory of the 
Physiology Department of the University of Padova. Subjects were instructed to avoid unusual exercise and big 
meals the night before the meeting. 
Overweight and obese girls came for the basal measurements five days before the start of the dietary protocol . 
The following controls were set on the starting day of the diet (t1), on the third (t3), on the fifth (t5), on the 
seventh (t7) and on the last day (t10) (Figure 3.1).   
On the basal control day, subjects signed the informal consent, were randomly divided in one of the three diet 
groups, received instruction about the diet protocol to follow and compiled a lifestyle questionnaire (Godwin, 
Streight et al. 2008). They were then weighed, their height was measured and they took a standard high carb 
breakfast (a high-carb 150 kcal muffin and one teaspoon of sugared instant tea dissolved in a glass of warm 
water). After breakfast, they completed the psychological tests.  At t1, t3, t5, t7 and t10 ketone bodies levels and 
glycaemia were measured, as well as appetite levels which was scored through a visual analogue scale (VAS). 
On the last control day (t10) subjects repeated the body impedance analysis, the body weight measure and, after 
breakfast (each group had a different breakfast according to the prescribed diet), the psychological tests. 
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Figure 3.1: overweight subjects’ study design. FBS:fasting blood sugar; KB: ketone bodies; VAS: visual analogue scale for 
appetite; BIA: bioelectrical impedance analysis; PT: psychological tests; inf. consent: sign of the informal consent. 
  
Diet protocols 
 
Diets tested were the Ketogenic Diet (KD), the Phytoketogenic Mediterranean Diet (KEMEPHY) and the 
Mediterranean Diet (MD) and were assigned randomly. A total of 13 girls followed the KEMEPHY diet, 16 
followed the KD and 16 the MD.  
 
The KD is a protocol in which all carbohydrate containing foods are excluded, whereas meat, eggs, fish, ham, 
green leafy vegetables, cruciferous, zucchini, cucumbers and eggplants can be assumed without any limit. This 
protocol allows the use of oil, lemon juice (2 tbs/day), spices and aromatic herbs with a limitation of the use of 
saturated fats like butter, margarine and lard. Coffee, tea and herbal tea could be sweetened with sweeteners. 
 
The KEMEPHY(Paoli 2011) is a phytoketogenic mediterranean calorie-controlled diet in which the subjects 
were allowed to eat with no limits green leafy vegetables, cruciferous, zucchini, cucumbers and eggplants. The 
quantity of meat, eggs and fish was limited to once a day (120 g of meat or 200 g of fish or 1 egg). Moreover, 
subjects daily consumed four food supplements and liquid herbal extracts. Food supplements are high proteins 
(19 g/portion) / very low carbohydrate (3,5 g/portion) formulas simulating the aspect and taste of common 
carbohydrate rich foods added with dry phytoextracts. Among the dry phytoextracts, there are 50 mg of 
Griffonia simplicifolia seed extract (for a total of 200 mg/day), which are useful against anxiety, thanks to the 
content of 5-hydroxytryptophan, a direct precursor of serotonin (Carnevale, Di Viesti et al. 2011). Liquid herbal 
extracts were used for their depurative/ draining / toning activity, useful to reduce some commonly reported light 
side effects of ketogenic diets as constipation, headache and halitosis (Table 3.1). 
 
The MD is a balanced calorie-controlled diet. The calorie intake was 1200 Kcal/day of which 15% were proteins, 
60% carbohydrates and 25% fat. In this protocol was highlighted the use of the typical ingredients of the 
mediterranean tradition, such as extra virgin olive oil, vegetables, fruits, fish, lean meat and whole grain cereals. 
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Table 3.1: KEMEPHY DIET 
KEMEPHY  
Daily Energy Kcal/day 882 
Protein, g/day (%daily energy) 106 (48) 
Carbohydrate, g/day (% daily energy) 20 (9) 
Fat, g/day (% daily energy) 42 (42) 
 
Glucose and ketones measurement 
 
Levels of KB and glucose were assessed using Precision Xtra® Blood β-Ketone Test Strips and Precision Xtra®  
(Chu, Jiao 2015) (Abbott Laboratories, Illinois 60064-3500, USA) and On Call Plus Blood Glucose Test Strips 
and On Call Plus® (ACON Laboratoires, San Diego, CA92121, USA). Blood β-Ketone Test Strips measure 
blood βOHB level in fresh capillary whole blood from the fingertip between 0.0 and 8.0 mmol/l.  The puncture 
was performed with the lancet Accu-Chek Softclix (Roche, Monza MB, Italy) on clean, dry and warm fingers. 
 
Body composition analysis 
 
Bioelectrical impedance analysis (BIA) is a reliable, non-invasive, safe and effective technique to measure body 
composition. Body composition was set through the four-electrode method using the instrument Akern STA-BIA 
(Akern s.r.l., Firenze, Italy) and its software BODYGRAM 3.0 (Savino, Cresi et al. 2004). 
 
Psychological tests  
 
Psychological tests consisted in a mood test, two cognitive tasks, one to investigate working memory and the 
second to stress executive functions, and in a VAS scale to test the appetite level.   
The mood test is the Italian Version of the Depression Anxiety Stress Scales-21. It is a self report measure 
formed by 21 items that reliably measure depression (lack of incentive, diysphorya and low self-esteem) as well 
as anxiety (somatic and subjective symptoms), stress (irritability, impatience, tension and arousal) and general 
distress (related to anxiety and depression) (Bottesi, Ghisi et al. 2015).  
The working memory test is an adapted version of the visuo-spatial n back (Cui, Bray et al. 2011, Haberecht, 
Menon et al. 2001). It consists in remembering the position of the letter “o” that, in each trial, could appear in 
different positions, since a 9-part grid divides the screen. In the control condition, the participant has to respond 
when the stimuli appears in the central part of the grid; in the low cognitive load when the letter is in the same 
position as the stimulus seen just before; in the high cognitive load when it matches the same position seen two 
positions before. The control condition is administrated between the other two. In total there are six blocks for 
the low cognitive load condition and six for the high one and the double amount for the control condition, for a 
total of 552 stimuli, 168 of which were targets and 384 were not-targets (Jaeggi, Buschkuehl et al. 2010). Each 
stimuli lasted 1500 ms, with a fixed inter-trial interval of 500 ms. 
The executive function test is an adapted version of the inhibitory control task (Cona, Arcara et al. 2013, 
Amodio, Ridola et al. 2010). The stimulus are letters that appear in the centre of the screen. The task is formed 
by two main parts. In the first one the participant has to respond when the letter x or y appear on the screen; in 
the second part the participant has to answer only when x precedes y and then vice versa. In the first part 406 
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stimulus are present, 66 of them of which are “go-trials” and in the second one 1746 letters are present, 254 of 
which are “go-trials” and 47 are “no-go” (Cona, Arcara et al. 2013). Each stimuli lasted 500 ms, without 
interstimulus interval, in order to have a high time pressure task. 
Each cognitive task is administered by E-prime software (Psychology Software Tools, Pittsburgh, PA) and 
before each part of the experiment a practice block was presented in order to make the participant familiar with 
the task. Both of the task needed 20-30 minutes to be completed. 
Motivation to eat and appetite were investigated by Visual Analog Scale (Hill, Blundell 1982), a test formed by 
6 scales. Each scale is 10 cm long and it is labelled with descriptions at both ends; moreover, every 10 mm, there 
are vertical lines labelled with numbers. Participants have to choose which part of the scale better describe how 
they feel. The scales investigate: appetite, fullness, desire to eat, how much would participant eat, urgency of 
eating and worries about food. Moreover, also the appetite (mean of all the responses) and gut based (hunger 
perceived) were taken into account (Stubbs, Hughes et al. 2000).  
 
Tests were performed after breakfast. On the basal meeting, breakfast was given to participants and consisted in 
a high carbohydrate muffin and a hot tea. On the last day of the diet (t10) breakfast was brought from home by 
each participant according to the followed diet protocol. 
 
STATISTICAL ANALYSIS 
 
For the analysis of body weight, BMI, BIA parameters, glycaemia and KBs we used the software GraphPad 
PRISM version 6.0h. and we performed the RM two-way ANOVA analysis with matched values stacked into 
subcolums with Sidak’s multiple comparisons test. In order to compare among eachother the measures of KB 
and glucose at each appointment, a Tukey’s test was also performed. For the analysis of the correlations between 
glycaemia and ketonemia and psychological test parameters, Pearson correlation test was carried out by SPSS 
software (IBM SPSS, version 22, Armonk, NY). 
 
RESULTS 
 
Body weight and fat mass 
 
Body weight decreased significantly (p < 0.0001) after the diet period in all three diet groups with no-significant 
difference between groups before and after diet.  Mean body weight of KEMEPHY group was 79.7 ± 8.7 kg 
before and 76.1 ± 8.7 kg after diet with a mean loss of 3.5 ± 0.6 kg. Mean body weight of KD group was 75 ± 
12.4 kg before and 71.9 ± 12.06 kg after diet with a mean loss of 3.1 ± 1.1 kg.  Mean body weight of MD group 
was  77 ± 5.6 kg before and 75 ± 5.2 kg after diet with a mean loss of 2 ± 1 kg.  
BMI decreased significantly (p < 0.0001) after the diet period in all three diet groups with no-significant 
difference between groups before and after diet. Mean BMI of KEMEPHY group was 28.4 ± 2.4 before and 27.1 
± 2.4  after diet with a mean loss of 1.3 ± 0.2. Mean BMI of KD group was  27 ± 1.9 before and 25.9 ± 1.9 after 
diet with a mean loss of 1.1 ± 0.4.  Mean BMI of MD group was 27.8 ± 1.8  before and 27 ± 1.7 after diet with a 
mean loss of 0.7 ± 0.3.  
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The weight of fat mass decreases significantly (p < 0.0001) after the diet period in all three diet groups with no-
significant difference between groups before and after diet. The mean weight of fat mass of KEMEPHY group 
was 31.7 ± 4.7 kg before and 29.7 ± 4.1 kg after diet with a mean weight loss of 2.1 ± 1.4 kg. The mean weight 
of fat mass of KD group was 28.8 ± 6.6 kg before and 27 ± 6.3 kg after diet with a mean weight loss of 1.8 ± 1.4 
kg. The mean weight of fat mass of MD group was 30.1 ± 3.9 kg before and 28.3 ± 4.5 kg after diet with a mean 
weight loss of 1.8 ± 1.4 kg.  
 
Glucose and ketones 
 
Glucose levels decreased significantly after KEMEPHY (p < 0.01) (mean glycaemia pre-diet: 95 mg/dl; post-
diet: 85.7 mg/dl with a mean reduction of 9 mg/dl) and KD (p < 0.0001) (mean glycaemia pre-diet: 92.8 mg/dl; 
post-diet: 80.6 mg/dl with a mean reduction of 12.2 mg/dl) with no-significant difference between diets. MD 
didn’t show any significant difference in glucose level between pre and post-diet (mean glycaemia pre-diet: 94 
mg/dl; post-diet: 92 mg/dl with a mean reduction of 2 mg/dl).  
Levels of βOHB rose significantly in both ketogenic regimens with no-significant difference between 
KEMEPHY and KD. Levels increased more in KD (p < 0.0001) (mean pre-diet levels: 0.2 ± 0.1 mmol/l; mean 
post-diet levels: 1.7 ± 0.8 mmol/l with a mean increase of 1.5 ± 0.8 mmol/l) compared to KEMEPHY (p < 0.001) 
(mean pre-diet levels: 0.1 mmol/l; mean post-diet levels: 2.1 ± 1.6 mmol/l with a mean increase of 2.1 ± 1.6 
mmol/l). 
KBs  increased significantly in KD group after 5 days of diet (t1 vs t5, p < 0.0001) whereas in KEMEPHY group 
KBs increased significantly after 7 days (t1 vs t7, p < 0.0001) (Figure 3.2). 
Glucose levels decreased significantly in KD group after 3 days (t1 vs t3, p < 0.05) but mostly after 5 days (t1 vs 
t5, p < 0.0001), whereas in KEMEPHY KBs increased signficantly after 5 days (t1 vs t5, p < 0.05) (Figure 3.3). 
 
 
Figure 3.2. Strongest signficant increase of KBs level from t1 in both ketogenic diet groups (KD and KEMEPHY).	
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Figure 3.3. Strongest significant decrease of glucose level from t1 in both ketogenic diet groups (KD and KEMEPHY). 
 
 
Psychological tests, glucose level and ketone bodies 
 
Mood 
No correlation was found between both glycaemia and ketonemia and depression, anxiety, stress or general 
distress, both in pre and post diet measurement.  
 
Cognitive functions 
• Working memory test (visuo-spatial n back):  no correlation was found between glycaemia and working 
memory results, both before and after the diet period. Ketone levels, as well, were not correlated with 
working memory results, both in baseline ans post-diet measurement  
• Executive function test (inhibitory control task): 
o Glycaemia: pre-diet levels were positively correlated with reaction time in the go-trials (r(43) 
= 0.358, p = 0.018). The same correlation was not found in the post-diet measuement, both 
considering all the participant together (r(44) = 0.132, p = 0.392) as well as dividing them by 
the type of diet followed: MD group r(15) = -0.025, p = 0.930 and ketogenic group 
(KEMEPHY and KD combined): r(29) = 0.179, p = 0.354. 
o Ketonemia: post-diet measurement showed a negative correlation between ketone levels and  
the accuracy of the no-go trials (r(29) = -0.455, p = 0.027), while in the baseline no correlation 
was found (r(28) = -0.007, p = 0.974). 
 
VAS scale (appetite) 
Glycaemia showed different correlation with VAS scale items. In the baseline measurement it was negatively 
correlated with how much would participants eat  (r(44) = -0.303, p = 0.045). Differently, in the post test 
analysis, the glycaemia showed a negative correlation with the feeling of fullness  (r(44) = -0.455, p = 0.002). 
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DISCUSSION 
 
Normal level of glycaemia are difficult to be defined (WHO 2006), so that the WHO defines “normoglycaemia” 
as the level below that of intermediate hyperglycaemia or prediabetes (110-125 mg/dL) (Makaroff 2016, WHO 
2006). Overweight and obesity are both risk factors for the development of diabetes (Sung, Jeong et al. 2012), 
but subjects of this study, despite being overweight, had a mean glycaemia below prediabetes levels (94±9 
mg/dL), maybe thanks to their young age. However, following a high carb breakfast these subjcets reported a 
slower reaction time in the go-trial of the executive function test. Given that in the post-diet control (mean 
glycaemia: 86 ±9 mg/dL) this correlation was not found, we can speculate that a high glycaemia, which is typical 
after the consumption of ultra-processed products high in sugar and refined grains (Lodi, Karsten et al. 2016) 
such as the high carb muffin given to participants in the pre-diet control of this study, couldn’t be the optimal 
choice as breakfast in the morning in order to achieve a good cognitive performance. In fact, data from this study 
show that glycaemia in the pre-diet control correlates positively with reaction time in the go-trials of the 
executive function test, which is a task that stresses functions which are frequently used during the day such as at 
work (the need to stay focused, the need to remember appointments) (Baddeley 2004, Wagner 1999), while 
studying (studying maths, problem solving, reading) (L.S. Siegel 1994, Raghubar, Barnes et al. 2010, Hambrick, 
Engle 2003)  and during social life (remembering names and facts) (Logie, Law et al. 2010) .  
Considering KBs, our study found a negative correlation between post-diet ketone levels and accuracy of the no-
go trials of the executive function test. This detrimental effects could be related with the short diet period and 
then the relatively low levels of ketonemia achieved (mean ketonemia: 2 ± 1.3 mmol/L) and could be reversed, 
as hypothesized previously (Holloway, Cochlin et al. 2011), by higher levels of KBs. 
Finally, our results showed that ketone levels (plasma βOHB) gradually increased during the first seven days, 
whereas the reduction of glucose levels mostly appeared on the third day, which is not consistent with previous 
findings which reported a gradual increase of KBs during the first four days and a deeper glucose level reduction 
on the fourth (Courchesne-Loyer, Croteau et al. 2016) . 
	
CONCLUSIONS 
Healthy young overweight subjects with fasting glycaemia below prediabetes level were negatively affected by a 
high-carb breakfast during an executive function test. Moreover, the effect of mild KBs levels (2 ± 1.3 mmol/L) 
negatively affected accuracy of the no-go trials of the executive function test. 
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